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ABSTRACT
Major medical needs may be achieved through regenerative medicine.
Nanotechnology has triggered a research revolution in many important areas such as the
biomedical sciences and bioengineering at the molecular level which has grown
significantly due to the availability of new analytical applications and tools based on
nanotechnology. Clinical conditions and diseases being targeted by nanotechnology
research include burns, Alzheimer's and Parkinson's disease, implant failure, improved
wound healing, birth defects, osteoporosis and congestive heart defects. Therapeutic use
of growth factors and drugs to stimulate the production and/or function of endogenous
cells represents a key area of regenerative medicine. The development of methods to
expand ex vivo and drug delivery through advances in cell culture and scaffold
technology have led to successful new treatment modalities for bone and wound repair.
The studies in this dissertation focused on several regenerative medicine
approaches, with a future goal of an implantable scaffold material that can efficiently act
as a repair material for wound healing and repair or as a replacement material for bones,
teeth and other tissues. In this study, two different materials were nanoengineered for
regenerative medicine applications. Anodization was used to produce nanoporous
titanium scaffolds. Electrospinning was used to form Poly (e-caprolactone) (PCL)
scaffolds, halloysite-PCL composite scaffolds and drug loaded halloysite-PCL scaffolds.
Cellular response was assessed in each study through cell-based assays, including the
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iv
PicoGreen DNA assay, the Coomassie Plus total protein assay, and the Alizarin Red
mineralization assay. Cell characterization methods were used to measure the potential of
these nanoengineered materials to enhance cell proliferation, functionality, tissue
formation and mineralization.
The results from the cell characterization assays suggest nanoporous titanium and
the type I collagen coated halloysite-PCL scaffold both hold promise for bone tissue
engineering and aiding in wound repair. Nanoporous titanium surfaces supported cell
growth, cell differentiation and mineralization and are more biologically supportive
compared to smooth titanium. The incorporation of HNTs up to 7wt%, within the PCLscaffold did not extensively change the morphology of the PCL scaffold. Scanning
electron microscopy and fluorescein isothiocyanate (FITC) labeling of halloysites
indicated the nanotubes were not incorporated into PCL fibers but clustered together to
form a ball-like structure that also linked adjacent fibers producing a complex, mesh-like
(and extracellular matrix-like) composite scaffold. Type I collagen coated halloysite-PCL
scaffold produced higher cell proliferation rates, increased protein synthesis and
enhanced mineralization in comparison with halloysite-PCL and PCL only scaffolds.
In a companion study, hallyosite-loaded scaffolds containing more than one drug
were created. Sustained release of Brilliant Green was achieved from both drug loaded
PCL scaffolds and the drug loaded halloysite-PCL scaffold. This data supports the
conclusion that drug loaded halloysite-PCL scaffolds may be a novel, biodegradable
material for wound healing, producing anti-bacterial materials, or enhanced tissue
bandages.
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CHAPTER 1
INTRODUCTION AND BACKGROUND
1.1

Nanotechnology for Regenerative Medicine

Nanotechnology is a fast developing field with a wide range of potential
applications. Nanotechnology involves understanding and controlling material at the
nanometer scale [1]. Improving lifestyles, an aging population, and ever-increasing
expectations for a better quality of life demand better, more proficient and cost effective
health care [2, 3]. Regenerative medicine is a multidisciplinary field with contributions
from biology, chemistry, engineering, material science and medicine [4]. The use of
nanotechnology in regenerative medicine holds much promise for the development of new
treatment modalities when applied to major medical challenges [4, 5]. The application of
nanotechnology in regenerative medicine may drastically change the treatment of diseases
in the future [1]. Nanotechnology has a broad area of application in regenerative
medicine, for example, in improving contrast imaging for bioimaging, in biosensors and
chemical sensors, tissue scaffolds, and in drug-delivery [6, 7]. The use of polymers for
controlled drug-delivery helps in sustained drug release and also increases the
effectiveness of the drug [1]. Nanoparticles and nanotubes are seeing increased use for
drug-delivery. Nanoparticles can circulate in the body and can be taken up by the cell
through endocytosis. Nanoparticles can also be used for diagnostic purposes. There are,
however, some obstacles in transforming current drug-delivery methods to nano-based
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therapies, for example, targeting nanoparticles at a specific site without being captured by
organs such as the liver and spleen [1].
In the last few decades, nanomedicines have started coming onto the market; for
example, superparamagnetic nanoparticles are used in MRIs for increasing contrast during
imaging [8, 9, 10]. Shortage of organs for organ transplantation may be overcome by
regenerative medicine [11, 12]. Regenerative medicine can be used to repair, retain, or
improve tissue and organ functions [1]. With the help of regenerative medicine, tissues
can be regenerated to replace or restore defective tissue or organs [4, 14]. Regenerative
medicine may be able to rejuvenate damaged tissues and organs by provoking previously
irrevocable organs to repair themselves [14].
At the present time, regenerative medicine has seen the development of tissue and
organs which can be grown in the lab and implanted when the body cannot repair itself
[14]. With the help of material science, engineering, and biology, tissue engineering can
be done using biomaterial and nanotechnology scaffolds created for tissue engineering
designs [1]. Using cells and scaffolds, regeneration of tissues can be achieved. Here, the
scaffold acts as a surface for cell proliferation [8, 4, 15]. Cell-surface interactions are very
important as it determines the success or failure of the implant; so it is essential that the
scaffold used produces the right signal to guide cell growth and tissue formation in a
suitable manner [4, 16].
In this dissertation, we have focused on three different applications of regenerative
medicine. Our first objective was to investigate an anodization technique to produce
surface modified nanoporous titanium that can be used as a potential system for
engineering a distinctive biomaterial. Our second objective was to fabricate a halloysitePCL (polycaprolactone) scaffold and assess the cell supportive ability. The final objective
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was to examine drug release from drug-loaded halloysite nanotubes, drug-loaded PCL
scaffolds, and drug-loaded halloysite-PCL scaffolds.
1.2

Nanoparticles and Nanotubes for Regenerative Medicine

Nanotechnology is

undergoing

fast

development,

and

new

research

is

continuously published [1, 10]. Nano means "one billionth" (10 - 9 ) and examples of
nanoparticles include buckyballs, liquid crystals, liposomes, nanoshells, quantum dots and
supramagnetic nanoparticles [17]. Carbon nanotubes and halloysite nanotubes are other
examples of nanotubes [18]. A couple of examples of potential application of
nanomaterials are biosensor and drug carriers [19]. Nanomaterials can be used as
intracellular drug carriers and as biosensors to monitor the real time level of
biomolecules, enzymes, and cell differentiation [20]. Present methods of judging cell
treatment include invasive and/or destructive methods, for example, tissue biopsies. Thus,
non-invasive methods are very advantageous. Examples of non-destructive nanoimaging
probes include nanoshells and quantum dots (QD) [18, 21].
1.2.1 Nanoparticles
1.2.1.1 Quantum Dots
Quantum dots are colloidal nanocrystalline semiconductors [22, 23]. Properties of
quantum dots depend on their size. Quantum dots can be used as fluorescent probes for
labeling [23]. To examine the cell and the cellular process, fluorescence labeling is used.
Conventional fluorescence labeling has some limitations for example including sensitivity
to thermal changes in local environment, blinking, photobleaching and lower contrast.
However, by using quantum dots that are colloidal metal particles, we can overcome these
limitations [23, 24]. The fluorescence wavelength of quantum dots depends on the size of
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quantum dots [24]. The quantum dot can be observed with high resolution compared to
fluorophores by electron microscopy [23].
1.2.1.2 Nanoshells
Nanoshells are nanoparticles which consist of a dielectric core coated with a
metallic layer [25]. Nanoshells are produced by layer-by-layer self-assembling and can be
used in drug-delivery [25]. Nanoshells can be manufactured by a one-step or two-step
approach [26]. This shell can be made up of oxides or metals, depending on intended use
[27]. As nanoshells are porous, drug-loaded nanoshells can be used for the delivery of a
specific drug at a targeted site. Targeted drug-delivery can be achieved by attaching
antibodies to the outer surface so that the nanoshell-antibody complex can bind to the
specific antigen in the body [26]. Nanoshells can be used for cancer therapy [26].
1.2.1.3 Liquid Crystals
Liquid crystal (LCs) is a photoswitch material. They have the ability to flow while
displaying anisotropic properties. They have solid-like and liquid-like properties [28].
Liquid crystals are sensitive to temperature, magnetic and electric fields [29]. They can be
used in targeted drug-delivery and topical applications [30]. In topical application, drug
diffusion depends on the amount of free water, length of diffusion pathway and
arrangement of structural elements [28].
1.2.1.4 Liposomes
Liposomal drug-delivery is a lipid-based drug-delivery for the treatment of cancer,
inflammation and pain relief [31]. It helps in reducing the dose dependent toxicity [32].
With the help of liposomes, drugs can be released all over the body. There are some
limitations with liposomes; one of them is that since lipids are natural products, the
immune system targets them, releasing the drugs too early [31].
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1.2.1.5 Superparamagnetic Nanoparticles
Superparamagnetic nanoparticles are commonly used in the MRI for increasing
contrast for imaging inflammation, tumors and degenerative diseases [33]. They can also
be used for targeted drug-delivery and gene transfection. Iron oxides are most frequently
used as core particles of superparamagnetic nanoparticles [33], Endorem is an example of
a superparamagnetic nanoparticle available in the market as a contrast agent for spleen
and liver disease detection. Lumirem is an example of a superparamagnetic nanoparticle
available in the market for detection of gastro-intestinal tract imagining [34].
1.2.2

Nanotubes

1.2.2.1 Carbon Nanotubes
Carbon nanotubes are made from a graphite sheet. There are two types of carbon
nanotubes, single wall nanotubes (SWNTs) and multiwall nanotubes (MWNTs) [35].
Carbon nanotubes are made by chemical vapor deposition, laser ablation of carbon, and
carbon-arc discharge [35]. There are many applications of carbon nanotubes, for example,
cells tracking, bio-sensing, drug-delivery, chemical sensing, and many more [35, 36, 37].
The price of carbon nanotubes depends on the quality and method of production. The
price of single wall carbon nanotubes is 50 to 100 times more than gold [38].
1.2.2.2 Halloysites
Halloysite nanotubes (HNTs) are natural nanotubes, very inexpensive and
available in large quantities. Carbon nanotubes cost approximately $500 per gram while
halloysite nanotubes cost approximately $500 per ton [39]. As halloysites have larger
surface areas, they can be used for drug-loading. Drugs of a smaller molecular size will
be trapped within the inner lumen of the halloysites, and drugs of a larger molecular size
attach to the outer surface of halloysites [40]. Other potential applications of halloysites
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include antifouling paint, fragrance, slow-release perfume, anti-sealants, pesticides, pest
repellents, slow release of cosmetics, in electronic industry and radiofrequency shielding
[39]. Thus, large surface area and low cost make halloysites superior compared to all
other nanoparticles and nanotubes.
1.2.3

Nanomodified Surfaces
Surface properties of the scaffolds are very important as cell-surface interactions

are dependent on the surface property of the scaffold. Cell-surface interactions impel
protein adsorption and, finally, lead to cellular interaction [41, 42]. Protein adsorption
relies upon the structure of the protein and the surface property [41]. Scaffolds used in
tissue engineering should resemble natural, extra-cellular matrices (ECM) to increase
implant biocompatibility [43]. Important surface properties of scaffolds to consider
include surface roughness, chemistry, hydrophilicity, and hydrophobicity. Natural bone
consists of organic compounds strengthened with inorganic compounds [44]. Collagen
fibers are the major structure seen at nano-scale in the bone. Ninety percent of organic
compound is collagen and the rest is noncollageneous protein and ground substances [44].
Thus if the scaffold has nanopores or nanofibers at the surface, it will resemble natural
extra cellular matrix. According to some studies, adsorption of particular proteins
increases subsequent cell adhesion to the material surface, for example, fibronectin.
Calcium phosphate crystals (CaP) are the key feature determining Osseo-integration to
surrounding bone tissue [45]. Growth factors mediate the differentiation of osteoblasts
from immature, non-calcium depositing cells to mature calcium depositing cells [46].
They are many types of scaffolds. They can be mainly subdivided in two types:
bio-resorbable and non-bio-resorbable. Scaffolds such as Poly(s-caprolactone )(PCL),
poly(d,l-lactide) PLA, Poly(lactide-co-glycolide) PLGA are all examples of FDA
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approved bio-resorbable polymers, and titanium is an example of a non bio-resorbable
scaffold [43].
The electrospinning technique is used for fabrication of the polymeric electrospun
scaffold. This technique also allows the incorporation of nanoparticles, enzymes, proteins
and chromophores directly during the preparation process. The application of these
biohybrid nanosystems is extremely wide and includes drug-delivery, catalysis, and
biosensors [47]. Titanium has good elastic modulus and mechanical properties similar to
that of natural bone under a load bearing condition [44, 48]. Smooth titanium is a not
sufficient bioactive to form a direct bonding with bone, which leads to implant failure.
Therefore surface modification should be done to create porous material by sand blasting
or plasma spraying techniques [49]. With the help of plasma spraying, hydroxypatite
(HA) or other calcium phosphates can be used for coating titanium. These coatings have
long term failures due to weak adhesion to the metal substrate and dissolution once
implanted [44, 49]. These problems can be overcome by the anodization process by
which we can produce micro and/or nanopores on the surface of the titanium implant
which helps in biological fixation to the surrounding tissue through bone tissue.
1.3

Tissue Engineering in Dentistry and Orthopedics

Tissue engineering is based on materials science and biocompatibility. It
incorporates cells, natural or synthetic scaffolds to create new tissues [50]. This field is
increasingly being viewed as having enormous clinical potential. At present, the
treatment of lost or deficient tissues includes prosthetic materials, drug therapies, and
tissue and organ transplantation [51]. Nevertheless, all of these treatments have some type
of limitations, for example, the failure of synthetic prostheses to replace any of the
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simplest structural functions of a tissue. Each year, many patients are registered on
transplantation waiting lists [52]. These problems have motivated the development of
tissue engineering. Tissue engineering will have a significant effect on dental and
orthopedic practice in the future, in the repair and replacement of mineralized tissues,
support of oral wound healing and the use of gene transfer [51].
In the United States each year, over half a million people undergo total joint
replacement [53]. The average lifespan of a reconstructive joint implant is approximately
15 years [54]. In all likelihood, this limitation means that each patient will have to
undergo a second surgery to maintain functionality [54]. There are many drawbacks with
replacement surgeries such as inferior recovery compared to the initial surgery,
postsurgical complications and pain. The most common explanation for the implant
failure is improper growth on the implant surface [44]. Currently, vanadium, cobalt,
chromium and smooth titanium are used in dental and orthopedic implants [44]. Out of
all these metals, titanium is most frequently used due to its tensile strength and corrosion
resistance [55, 56, 57]. However, the problem with titanium implants is that they does
not mimic the natural bone structure, so there is a higher chance of implant failure [58].
Natural bone is nanoporous at the surface [44]. Therefore, if we modify the surface of
titanium such that it becomes nanoporous, these changes may help in increasing the life
span of the implant. One of the objectives is to produce nanoporous titanium by the
process of anodization.
1.4

Nanotechnology in Drug Release

Controlled drug-delivery is one of the most promising biomedical applications of
nanotechnology. The use of nanomaterials as nanocarriers for improving delivery
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methods has shown to be advantageous technically and viable economically [59]. The
present generation of drugs is given systemically. Some of the harmful effects and
problems of systemic drug-delivery include drug solubility, metabolism and excretion of
drugs, trouble in maintaining drug concentrations and toxicity to non-target tissues [60].
Use of nanotechnology in drug-delivery methods may diminish current problems in drugdelivery [60]. Carbon nanotubes, halloysite nanotubes, superparamagnetic nanoparticles,
liposomes and nanoshells can be used for targeted drug-delivery [61]. Drugs can be
encapsulated in any of these nanoparticles and nanotubes, and used for drug-delivery
[62]. This encapsulation protects drugs from metabolism or excretion [63]. This system
can also be used in an internal and external signal triggered release. Examples of external
signals include magnetic field, ultrasound, infrared light and radiofrequency; pH is an
example of an internal signal [64].
Controlled release of antibiotics and antiseptic drugs from halloysite PCL
scaffolds can be used for wound healing. The basic concept of healing in any tissue type
(for example bone or skin) is the same. The second objective of this project is to
electrospin a halloysite-PCL scaffold, to find the best concentration and the exact location
of the halloysite in the halloysite-PCL scaffold by Fluorescein isothiocyanate (FITC)
labeling of the halloysite and to check its biocompatibility. The third objective of this
project is to check the drug released from drug-loaded halloysites, PCL scaffolds and
halloysite-PCL scaffolds.
1.5

Project Objectives

1. To find out the best parameter of anodization to produce nanoporous titanium.
Compare osteoblast cell proliferation and differentiation on smooth versus nanoporous
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titanium surfaces. Nanoporous surfaces should lead to better cell proliferation and
differentiation leading to enhanced implant durability and osteointegration for patients
with degenerative joint problems, as the surfaces are similar to natural bone surface.
2. To electro-spin the halloysite-PCL scaffold and find the best concentration and the
exact location of the halloysite in the halloysite-PCL scaffold by Fluorescein
isothiocyanate (FITC) labeling of the halloysite, compare osteoblast cell proliferation and
differentiation on PCL and halloysite-PCL scaffolds.
3. To load halloysite nanotubes with drugs, for example antibiotics and antiseptic, measure
the drug released from the halloysites, PCL scaffolds and halloysite-PCL scaffolds.

CHAPTER 2
NANOFABRICATION FOR TISSUE ENGINEERING AND
REGENERATIVE MEDICINE
This chapter describes the major topics of this dissertation. Nanofabrication of
scaffolds can be done using many varied techniques [65]. These techniques can create
unordered or ordered surfaces. Colloidal lithography, chemical etching, anodization,
polymer demixing and electrospinning are example of nanofabrication technique that
create unordered features [65, 66]. Photolithography and electron beam lithography are
examples of nanofabrication techniques that create ordered features

[65, 66].

Nanomodified surfaces resemble the nanoscale features presented to cells by extracellular
matrix proteins. Collagen is major extracellular matrix proteins; it has a specific
nanotopography that supports cell attachment, differentiation and functionality [66].
Tissue engineering has emerged as potentially superior therapeutic option in the
field of regenerative medicine. Tissue engineering includes the use of cells and
biomolecules in artificial or natural materials which can replace body functions that have
been lost or damaged due to disease or accidents [12, 8]. Tissue engineering uses scaffoldguided tissue regeneration [67]. This process includes the seeding of scaffolds with cells
which then differentiate and produce tissue mimicking natural tissues [68]. Once tissue
engineered constructs are ready, they are implanted into the patient to replace unhealthy
or injured tissues [68]. As time passes, host tissues invade the scaffold with blood vessels
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and nerves, and with the scaffold degraded over time. Examples of successfully tissue
engineered tissues include cartilage, bone and skin for autologous implantation [4, 69].
There are some implants which are not biodegradable, for example, titanium. Successful
clinical use of resorbable, non-resorbable, bioinert and bioactive implants will
significantly advance medical needs [70, 71, 72].
In this study, we used two different types of scaffolds: anodized titanium and
halloysite-PCL scaffolds. Anodized titanium can be used in orthopaedic and dental
implants. Halloysite-PCL scaffold may have use in drug-delivery, wound healing and
tissue engineering applications.
2.1

Titanium Implants

Titanium implants are used in dental and orthopedic application [73]. It is difficult
to produce properties of bone in synthetic implants [74]. These synthetic implants do not
give satisfactory results. The average life of a knee, hip or ankle implant is 10 to 15 years
[75]. Accordingly, patients need to undergo repeated implant surgery. The reason for
implant failure is, that implants are unable to produce a sufficiently strong cellular
response and so integrate the implant into surrounding tissue [76]. In this study, we
examined if nanoporous titanium, manufactured by anodization, can be used to support
cell attachment and functionality. Nanoporous titanium has a unique property due to
nanopores that cover its surface; these nanopores provide improved magnetic, electrical
properties and better structural integrity, leading to a better cellular response [76, 77, 78].
2.1.1

Anodization of Titanium
Titanium has corrosion resistant properties due to its titanium oxide layer [79].

This layer is formed automatically when titanium is exposed to the air [80]. Still, this
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layer is not reactive enough, so it is unable to form a direct bond with the bone [81]. Due
to this insufficient osseointegration, implant life is very short. Anodization should to
improve surface properties creating a nanoporous surface similar to natural bone [82]. An
oxide layer forms on the anode surface, when a constant voltage is applied between the
anode and cathode [83]. The chemical reactions for anodizing titanium are described
below. Figure 2.1 shows anodization set-up. Figure 2.2 shows smooth titanium used in the
anodization.
Chemical reaction at Ti and Ti oxide interface:
Ti <-• Ti2+ +2e"
Chemical reaction at Ti oxide and electrolyte interface:
2H 2 0 <-• 2 0 2 > 4H+
Chemical reaction at both interfaces:
Ti2+ + 20 2 " <-• Ti0 2 + 2e
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Voltage Source

Titanium
(Anode)

Platinum
(Cathode)
v

/

Electrolyte

Figure 2.1 Anodization Set-Up [84].
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Figure 2.2 Smooth Titanium (0.5in x 0.5in).
As titanium oxide has more resistance compared to the electrolyte and the metallic
substrate, the voltage will drop over the titanium oxide film on the anode [83]. Provided
the voltage applied is sufficiently strong to drive the ion conduction through the oxide
layer, the oxide film will keep on growing. Thus, the final oxide film thickness is almost
linearly dependent on the applied voltage [83]. Anodization of titanium can be done with
different chemicals, for example, in H2SO4/HF solutions, phosphate electrolytes, chlorideion-containing media, acid/ethanol mixture [85, 86, 87, 88].

16
2.1.1.1 Effects of Processing Parameters
After the anodization process, morphology, chemistry and roughness of oxide film
formed differ depending on the processing parameter used. These processing parameters
are current density, voltage, pH, electrolyte composition, time and temperature [44].
Different types of acids, alkaline solutions and neutral salts are used as electrolytes for the
anodization process. Commonly, it was observed that compared to all the electrolytes the
titanium oxide layer thickness in H 2 S0 4 was the highest [44]. In this study, therefore we
have used H2SO4 and HF as electrolytes.
2.1.1.2 Anodized Oxide Film
Properties of anodic oxide films include surface roughness and porous texture.
After anodization, the thickness of the protective oxide layer increases and it could lead to
less ion release in the human body. The oxide barrier layer is considered to contribute to
the improvement of corrosion resistance [89]. Structure and properties of anodic oxide
films depends on the processing parameters [90].
2.1.2

Chemical Properties
Currently, many different implant materials are under investigation including

titanium, ceramics, polymers, and biologically synthesized substances. Compared to all
material, titanium is the best material because it is more biocompatible, durable and
corrosion resistante [79]. Still, according to previous studies, metal such as smooth
titanium, failed to produce proper osseointegration [78]. Accordingly, in this study we
modified the surface of smooth titanium to obtain a surface that would promote
osseointegration.
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2.1.3

Need for Long Lasting and Better
Quality Implants
Current implants do not help in changing bone mass that occurred due to

osteoporosis and fractures. The average life of these implants is 10 to 15 years [75]. The
lifetime of the implant is very short for infants and young people. Bone implants replace
missing bone and provide surface where bone and a vascular network can be regenerated
and better osseointegration can occur [91]. Once the implant is implanted at the injured
site, protein from blood, bone marrow and other tissues, for example, fibronectin and
vitronectin, starts adhering to the implant surface [92]. These proteins then control
subsequent cell adhering. Protein bound to the implant surface osteoblast cells then binds
to the implants. Thus, it is very important to have a proper surface where initial protein
adsorption occurs [93]. Here, chemical and physical properties of the implant's surface
determine the initial adsorption of the protein. So the goal is to produce implants with
such chemical and topographic properties that may have the potential to solve current
problems in orthopedic and dental implants [76, 77, 78].
2.1.4

Osteoporosis and Implants
Osteoporosis is a bone disorder resulting in reduced bone density and bone

strength [94]. Osteoporosis can be asymptomatic.

Symptoms and problems of

osteoporosis include fractures, pain, and deformity [94]. Osteoporosis is usually found in
the aged population, especially women, who are very prone to this disorder. Implants that
provide better structural integrity by providing quicker and better cellular response are
very useful for repairing a fracture in osteoporosis patients [76, 78]. Anodized titanium
may prove useful in generating faster and better cellular response in osteoporosis and
aged people.
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2.2

Electrospinning Halloysite-PCL Scaffolds

Scaffolds of microscale and nanoscale polymer fibers can be fabricated by placing
a polymer solution to an electric field [96]. This technique is known as "electrospinning."
The electrospinning set-up is shown in Figure 2.3. The electrospining set-up consists of a
syringe pump, a high voltage source and a collector [97]. Surface tension holds a polymer
solution at the tip of the needle. Higher voltage in the needle causes induction of charges
in the polymer solution. The polymer jet is formed when the charge repulsion within the
solution overcomes the surface tension [98, 99, 100]. Fluid jet experience instability
when jet leaves the tip of the needle. This results in the bending of the fluid jet due to
applied electric field [101]. During the polymer jet travel path, the evaporation of the
solvent occurs, and the fibers are collected on a collector plate. Solutions with higher
conductivity have more tendencies for jet formation [102, 103, 104]. In this study, we are
trying to electrospin halloysite-PCL composite scaffolds and drug-loaded halloysite-PCL
scaffolds.
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Collector

Sample

n
ScaffoW

HIGH VOLTAGE (3ENRATOR

Figure 2.3 Electrospinning Set-Up [95].
There are different parameters which can affect the diameter of the electrospun
fiber including distance between needle tip and the collection screen, the rate of the
syring pump, voltage applied and solution parameters [105]. Solution parameters include
weight percent of polymer, weight percent of solvent, molecular weight of polymer,
viscosity and surface tension [105]. There are some other parameters which have some
effect on fiber morphology; these parameters includes includes air-flow, humidity and
temperature [105].
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2.3

Drug-Delivery

Drug-delivery, is one of the promises of nanotechnology. The use of
nanomaterials as nanocarriers for improving the delivery methods has been advantageous
technically and viable economically. These nanocarriers, formed by the process of
nanoencapsulation, are of two types: nanospheres and nanocapsules [106]. Halloysite is
an example of nanocapsules.
2.3.1 Halloysite
Halloysite is a naturally occurring nanotubular clay particle [107]. It is mined
from natural deposits in different countries. Utah has the biggest halloysites deposit
in the USA [108]. Halloysite is a two-layered aluminosilicate [109]. It has an empty
tubular structure. Halloysite is chemically analogous to kaolinite [110, 111, 112, 113,
114]. Hydrothermal processe convert kaolinite to halloysites [115]. This process takes
more than millions of years. The strain caused due to lattice mismatch between adjacent
silicone dioxide and aluminum oxide layers cause them to become are rolled into
nanotubes [110, 111, 112, 114]. Figures 2.4 and 2.5 show SEM images of halloysite.
Figure 2.6 shows TEM image of halloysites.

21

J

.

'

T

.

"

.

I

*

«

.

«

f

r

4

1

•j

vV'<

t " •

•, X

Ji

A

v' . S\

• *•"
* • * ; • .

•..

./

••

*

V

V
<t

»
• * ,

'A.

\

\

s

'I C*
»

'

«

"O,*

V *» * . •

»

's

*

\

V

.<- s

V

V.v

• 1 :
4 »

v * .
"

• * \

• A

1

i-

*

K

•

f .
•* _

« » .

*

.

i •

.,v..

-i » - - ' v

«• •• i

*

Figure 2.4 SEM Image of Halloysites.

^

- ^

22

fc*

Jr is.— _ *.- #

y
50 nm
Figure 2.5 SEM Image of Halloysites.

23

f *

*

"X
t

X

#Y

~V

x
•'•-

-V

100 nm

Vv
Figure 2.6 TEM Image of Halloysites.

2.3.2

Structure and Chemical Constitution of Halloysite
Halloysite occurs as a hydrated mineral; it contains H 2 0 in the interlayer.

Hydrated halloysites are represented as halloysite (10 A). Heating hydrated halloysite (10
A) converts it to dehydrated halloysite (7 A) [116]. The chemical formula of halloysite
is Al 2 Si205(OH)4.2H 2 0. The chemical formula is alike to kaolinite, except the
existence of an extra water monolayer between the adjacent layers [117]. Figures 2.4 2.6 show the halloysite nanotubes. The outside diameters of the halloysite vary from 50 to
70 nm [118]. The average inner diameter is 15 nm [118]. The lengths of halloysite vary
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from 1 to 1.5 urn [118]. The morphology of halloysite nanotubes vary depending on
chemical composition, crystal structure and effect of dehydration [119].
2.3.3

Physical and Chemical Properties of Halloysite
Halloysites have large specific surface areas [120]. According to a study done by

Churchman et al., small halloysite particles (in terms of width) were plentiful with fine
cylindrical pores, whereas larger halloysites (in terms of width) had very few pores
[121]. Due to this reason, the halloysites are able to absorb a fairly large class of
compounds. This absorption includes drugs, biologically active agents and anticorrosion
agents [108]. If suitable pre-treatment of halloysite is done, then both hydrophilic and
hydrophobic compounds can be entrapped in halloysites [112]. The loading of small
molecules occur by intercalation of small molecules into their interlayer space [122, 123,
124] whereas, larger molecules (proteins) binds to outer face. Intercalation does not take
place with bigger molecules because of their large molecular size [111, 125]. Halloysites
can be used as a enzymatic nano-reactor [108]. Different metals (iron, copper etc.) can be
used to form conductive and paramagnetic coating on halloysites [108]. The inner surface
of halloysite is similar to alumina and the outer surface of the halloysite is similar to
silica. When pH is below 8.5, halloysites have inner surface positively charged and outer
surface negatively charged. This helps in loading negatively charge molecules in inner
lumen of halloysites. Surface charges are pH-dependent [110, 40]. The capillary force
facilitates adsorption of several materials. The capillary force is calculated by, h =
(2y cosG) / (pgr) [126]. Here p is density of liquid, r is radius of halloysite and g is
acceleration due to gravity. For a water-filled tube in air at sea level, h = (1.4 x 10 "5)/r.
Halloysite has average inner radius of 7nm, so the capillary force this halloysite in
terms of the height of the water column is h - 2000 in. Thus, halloysites have higher
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capillary forces so they can quickly adsorb numerous materials [126]. These drug-loaded
halloysites can be added to PCL-chloroform mixture and drug-loaded halloysite-PCL
scaffold can be prepared and may potentially be used as drug-loaded bandage.

CHAPTER 3
METHODS AND INSTRUMENTATION FOR EXPERIMENTATION
AND ANALYSIS
This chapter describes the instruments and methods used in these projects.
3.1

Instruments

Current research involves many different instruments; different instruments were
used in this project according to need. The anodization set-up was used for anodizing
titanium at room temperature. The electrospinning set-up was used for spinning PCL
scaffolds, Halloysite-PCL scaffolds, drug-loaded PCL scaffolds, drug-loaded halloysitePCL scaffolds and FITC labeled halloysite-PCL scaffolds. The scanning electron
microscope (SEM) was used for observing surface modification on titanium after the
anodization process and fiber organization in PCL scaffolds and halloysite-PCL scaffolds
after electrospinning. An epifluorescence microscope was used to observe the location of
FITC labeled halloysites in a halloysite-PCL scaffold. A benchtop vacuum station was
used for loading drugs into the halloysites. Ultraviolet visible (UV-Vis) spectroscopy was
used to measure the different drugs released from the halloysites, drug-loaded PCL
scaffold and drug-loaded halloysite PCL scaffolds. A visible spectrophotometer was used
for Coomassie plus protein assay and alizarin red staining.
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3.1.1

Anodization Set-Up
Figure 3.1 shows the anodization set-up used in this project. The anodization

technique has been used widely for different metals, for example, aluminum, titanium,
zinc and magnesium [127]. Anodization is an electrochemical conversion process and
increases the oxide layer on the metal surface [128]. As the part to be treated is kept at
anode, this process is known as "anodization". This process increases the wear resistance
and the corrosion resistance [129]. Anodization changes the surface texture of the metal
This process can be performed in a variety of chemical solutions; chromic acid, oxalic
acid, phosphoric acid, sulfuric acid, boric acid and organic acids [129, 130, 131]. In this
study, sulfuric acid and hydrofluoric acid were used for the anodization of titanium.

Figure 3.1 Anodization Set-Up (Located at IFM).
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3.1.2

Scanning Electron Microscope
Figure 3.2 shows the scanning electron microscope (SEM) used in this project.

The scanning electron microscope is a type of electron microscope which uses an
electron beam as an alternative of light to form an image [132, 133]. An electron gun
produces a beam of electrons at the top of the microscope. The electron beam passes
through electromagnetic fields and lenses. These electromagnetic fields and lenses focus
the electron beam on the sample. As soon as the electron beam strikes the sample, X-rays
and electrons are expelled from the sample. A detector collects and converts all
secondary electrons, backscattered electrons, and X-rays into a signal. These signals are
then sent to a screen to produces the image [134, 135, 132]. The signals that are received
from the electron-sample interactions disclose information about the sample including
structure, composition, morphology and arrangement of materials making up the sample
[132, 133]. SEM has developed new areas of study in the science communities. As the
SEM uses electromagnets instead of lenses, the researcher has more control over the level
of magnification. Besides these benefits, the outstandingly clear images make the SEM
one of the most helpful instruments for research [136, 132]. In this study, SEM was used
for observing surface modification on the titanium after the anodization process. It was
also used for observing fiber and halloysite organization in PCL and halloysite-PCL
scaffolds.
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Figure 3.2 Scanning Electron Microscope (Located at IFM).
3.1.3

Electrospinning Set-Up
Figure 3.3 shows the complete electrospinning set-up. Electrostatic forces are

used in the electrospinning set-up for the production of polymer fibers [137]. Process of
spinning fibers using electrospinning set-up is known as "electrospinning process". In
this process, a jet of polymer solution is created by applying voltage. In electrospinning
set-up, one electrode is attached to syringe containing spinning solution, and the other
electrode is attached to a collector. When the strength of the applied electric field is
increased, the solution at the tip of needle elongates to form a Taylor cone (conical shape)
[137]. When a significant electric field is achieved, the repulsive force overcomes the
surface tension and the jet of solution formed from the Taylor cone. During travel,
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solvent evaporates from the polymer jet and polymer fiber is formed; these fibers are
arranged randomly on collector plate (metal screen) [138, 139, 140]. In the current
research, an aluminum screen is used as a collector plate Figure 3.4 shows a syringe
pump and syringe. Figure 3.5 shows a collector plate, and Figure 3.6 shows a high
voltage electricity source.

Figure 3.3 Electrospinning Set-Up (Located at CTH).
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Figure 3.4 Syringe Pump and Syringe (Located at CTH).
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Figure 3.5 Collector Plate (Located at CTH).
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Figure 3.6 High Voltage Electricity Source (Located at CTH).
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With the help of the electrospinning process, we can make fibers with diameters
ranging from a few micrometers to a nanometer [141, 142, 143]. Fibers produced by this
process have a larger surface area per unit mass. Thus, a scaffold collected on a collector
plate can be used for many different applications: tissue engineering scaffolds, filtration
of submicron particles and wound dressing band aid [140]. In this study, electrospinning
was used to spin PCL scaffolds, halloysite-PCL scaffolds, drug-loaded halloysite-PCL
scaffolds and FITC labeled halloysite-PCL scaffolds.
3.1.4 Epifluorescence Microscope
Figure 3.7 shows the epifluorescence microscope used in this project.
Epifluorescence is an optical arrangement used in a fluorescence microscope. In this setup, light is focused on the sample and collected from the sample by objective lens [144,
145]. As separate lens are used in transmitted fluorescence microscope to focus UV light
on the sample, the epifluorescence microscope is more efficient compared to transmitted
fluorescence [146]. In the epifluorescence microscope, both the excitation and emission
light pass through the objective lens. Thus, in epifluorescence, an important aspect is
separation of the excitation light from the emission light coming from the sample [145].
In this type of microscope, the UV light strikes on a dichroic mirror. This mirror returns
one range of wavelengths and lets another range of wavelength to pass through. Here, the
mirror returns the UV light to the specimen, which excites fluorescence within the
sample. The objective lens collects the fluorescent light produced by the sample, and this
light then goes to the dichroic mirror and a filter. Here, wavelengths other than
fluorescent are eliminated, so only fluorescent light travels to the eyepiece [147, 145]. In
this project, an epiflurescence microscope was used for finding the location of FITC
labeled halloysites in halloysite-PCL scaffolds.
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Figure 3.7 Epifluorescence Microscope (Located at IFM).
3.1.5 Benchtop Vacuum Station
Figure 3.8 shows the benchtop vacuum pump used in the current study. It creates
a vacuum in the chamber by removing air from the chamber. It is used for drug-loading
in the halloysites. Halloysites are mixed with a drug solution and kept in the chamber;
when the vacuum pump starts, it removes the air from the halloysites and loads the drug
into the halloysites.
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Figure 3.8 Vacuum Pump (Located at IFM).
3.1.6

Ultraviolet Visible Spectroscopy
Figure 3.9 shows the ultraviolet-visible (UV-Vis) spectrophotometer used in this

project. The ultraviolet-visible spectrophotometer is used for examine samples in the
visible and ultraviolet regions of the electromagnetic spectrum [148].

In UV-Vis

spectroscopy, the wavelength and maximum absorbance of compounds are determined by
examining electronic transitions. Concentration or molar absorbance of a sample can be
determined by beer's law if the molar extinction coefficient is known or the molar
absorptivity of sample is known [149, 150, 151]. As molar extinction coefficients are
precise for specific compound, UV-Vis spectroscopy can be used for

finding

an
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unknown compound's identity [151]. In this study, UV-Vis spectroscopy was used to
determine the amount of drug released from the halloysites, PCL scaffolds, halloysitePCL scaffolds.

Figure 3.9 Ultraviolet-Visible Spectrophotometer (Located at IFM).
3.1.7

Visible Spectrophotometer
Figure 3.10 shows the visible spectrophotometer used in this study. It is also

known as a colorimeter, as it determines absorbance of light in the visible region [152].
In the visible spectrophotometer, light coming from the tungsten filament lamp is focused
onto the entrance slit using condensing lens. The light from the slit is focused on the
cuvet containing the sample. When light hit the curvet containing sample, the beam of
light is dispersed and the spectrum is obtained. This spectrum, then, is focused on the
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exit slit. The visible Spectrophotometer is used for qualitative and quantitative analysis
[152, 153, 154]. In the current project, a visible spectrophotometer was used for
Coomassie plus protein assay and alizarin red staining.
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Figure 3.10 Visible Spectrophotometer (Located at BEC).
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3.1.8

Fluorescence Plate Reader
Figure 3.11 shows the fluorescence plate reader used in this project for PicoGreen

Assay. In this instrument, top and bottom readings are available to read anything from 6
wells to 384 wells at a same time. The FLx800™ is a multi-Detection microplate reader.
It has excellent specifications and the design incorporates powerful performance at much
lower price [155].
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Figure 3.11 Fluorescence Plate Reader (Located at IFM).
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3.1.9

Inverted Microscope
Nikon TSlOO is an inverted micioscope (Figure 3.12). It produces intensely clear

and sharp images. Applications of an Inverted microscope include blood typing, genetic
engineering, developmental genetics, electrophysiology, pharmacology, tissue culture
and neurochemistry [156, 157].

Figure 3.12 Inverted Microscope (Located at BEC).
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3.2

Cell Assays

There are many different techniques to determine cellular response. We have used
three of them to determine cellular response including PicoGreen assay, Coomassie plus
protein assay and alizarin red staining.
3.2.1

PicoGreen Assay
PicoGreen assay is used to quantify double-stranded (ds) DNA within a sample.

PicoGreen is a fluorescent nucleic acid stain, which is very sensitive and specific for
double stranded DNA, enabling researchers to quantitate as little as 250pg/ml ds DNA in
a 200(0.1 assay volume. Results of PicoGreen assay are not affected even in the presence
of salt, urea, ethanol, chloroform, detergents, protein and agarose compared with
traditional Hoechst or UV absorbance-based ds DNA quantification methods [158]. Thus
in this study, the PicoGreen assay was used to obtain measurement on the rate of cell
proliferation determined by quantifying ds DNA content produced by dividing cells.
3.2.2

Coomassie Plus Protein Assay
Coomassie plus protein assay is a colorimetric method for total protein

quantitation. In an acidic medium, when Coomassie dye attach to protein, the color
changes from brown to blue. Here change in absorption maximum also takes place from
465nm to 595nm [159]. In the current study, we examined how the surface modification
of titanium can increase the rate of protein synthesis. We also tried discovering the effect
of the addition of halloysites in PCL scaffold.
3.2.3

Calcium (Alizarin Red) Assay
Calcium deposition by cells in culture can be estimated with help of alizarin red

staining. To determine amount of calcium deposition, distaining of stained monolayer
should be done and assayed. Alizarin red assay is more sensitive compared to

42
cetylpyridinium chloride extraction method [160]. Using alizarin red staining method, a
detailed analysis of mineralization can be done by microscopy, and quantification can be
done by visible spectroscopy. Alizarin red staining can be used for osteogenic compound
screening, stem cell evaluations, tumor characterization and many more [160]. This assay
gives more reliable results for weakly mineralizing samples. Alizarin red stain forms
alizarin red S- calcium complex in the presence of calcium [161]. The reaction complex
formed can be recovered and measured at 410nm.

CHAPTER 4
OSTEOBLAST CELLULAR RESPONSE ON NANOPOROUS
TITANIUM
4.1

Introduction

As titanium has outstanding mechanical and corrosion resistance properties, it is
extensively used in dental and orthopedic applications [162, 163]. The corrosion
resistance property of titanium is due to titanium oxide (Ti02) layer [164, 165]. This layer
is formed automatically when titanium comes in contact with an oxygen containing
environment. The titanium oxide layer is not bioactive, due to this it is unable to form a
proper bonding with bone; this leads to a lack of osseointegration. This may cause
implant failure [44, 93]. Thus, improving surface properties of titanium implants, which
determine cell-surface interactions after implantation, will help extend the life of titanium
implants. There are different surface modification techniques available, for example
plasma spraying, acid etching and sand-blasting [166]. The organic matrix of bone
contains type I collagen. It has specific nano-topography [44]. These indicate that bone
cells may be more used to an environment in nano-scale rather than micro-scale [93] so,
in this chapter; we are discussing the anodic oxidation (anodization) technique for surface
modification. In this project, the strategy is to modify titanium to possess nanoporous
and/or microporous surface features as natural bone is nanoporous. This chapter will
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describe the anodization and different processing parameters and biological responses of
anodized nanoporous titanium.
Human bone is composed of collagen, proteoglycan and calcium phosphate
crystals [167]. It is a rigid structure. Bone is considered to be nanophase material; it has
nanometric surface roughness [93]. Bones are made up of intercellular calcified material,
known as the bone matrix and three cell types: osteocytes, osteoblasts and osteoclasts
[168; 169; 170]. Bone is composed of 30% of bone matrix and 70% of bone salts [171]
4.1.1

Bone Fracture Repair
Hematoma formation occurs as an initial leading process in bone repair.

Subsequently, infiltration of monocyte, macrophage, lymphocytes and polymorphnuclear
cells occur, helping in removing the tissue debris [172]. After that, the fibroblast come
into action and produces the granulation tissue and help in angiogenesis [173, 174].
During the repair process, the mesenchymal cell differentiates into osteoblast cells, which
helps in laying down matrix [174], known as a callus. This callus is very weak and further
strengthened by the osteoblast. Remodeling is the last process in bone repair. During
remodeling, weak tissue is resorbed by the osteoclast and replaced by osteoblast, forming
the new bone [172, 174].The steps of the bone repair process are shown in Figure 4.1.
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Inflammatory Phase

J L
Reparative Phase (Callus Formation)
Remodeling Phase
Figure 4.1 Bone Repair Process.
4.1.1.1 Current Strategies for Bone Repair
Usually, bone regenerates on its own but in certain pathological states like
infection, excessive injury in accident or with immunocompromised, bone loses its
potential to regenerate. In these scenarios, bone grafts are employed to replace damaged
bones. There are several types of grafts like autografts, allografts, xenografts and
alloplasts [175]. Due to issues of availability, immune rejection and transmission of
potential infectious diseases, alloplasts are nowadays the preferred modality [176].
4.1.1.2 Limitations of Current Implants
Usually, implants are made up of different metals like vanadium, titanium and
cobalt-chromium. Out of these metals, titanium is used very commonly in dental and
orthopedic implants as it is more biocompatible and provides more mechanical support. It
has also shown a lower propensity for corrosion [79]. Despite all of these advantages, the
current clinical issue is about longevity of titanium implants [44]. This study attempts to
understand osteoblast cell adhesion, growth and functionality on smooth and nanoporous
titanium, and tries to find out what modifications can be done on titanium so that the life
of implants can be increased.
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4.1.2

Dental Structure
The core of the human tooth is made up of dentin. Dentin is calcified connective

tissue. Dentin is covered by enamel which is an extremely hard and brittle material.
Compared to all other skeletal elements, teeth are more resistant to all kinds of physical
and chemical destruction [177]. The cervical level of the tooth is surrounded by the
gingiva and the alveolar bone [178]. Three cell types are responsible for alveolar bone
formation: osteoblasts, osteocytes and osteoclasts [179].
Replacement of the missing teeth is very important; for this purpose, titanium
implants are used. In the current study, we used osteoblast to grow on smooth and
anodized titanium to see which one will help in increasing alveolar bone volume faster
and better as dental implant technology is dependent on bone volume.
4.1.3

Missing Teeth
People sometimes have a missing tooth or teeth since birth, and many lose a tooth

or teeth due to disease, age, or accident. This problem of missing or broken teeth can be
treated. On the other hand, ignoring these problems may lead to extra tooth and bone loss.
Thus, it is important to take care of missing teeth as soon as possible. If missing teeth are
left untreated, then other teeth start moving into the space. Opposing teeth also start
moving when opposing teeth are missing. Thus, to keep all other teeth in the right
position, it is important to treat missing teeth.
4.1.4

Implant Bone Volume
Bone volume is one of the important factors for implant success. It is essential to

assess this parameter prior to implant placement. An adequate amount of bone available
for implant placement is one of the requirements for implant success [180]. Long-term
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tooth loss can decrease bone volume in patients [181]. With proper treatment planning,
the bone and peri-implant soft tissue can be reestablished. Providing the support required
for long-term function of implant. Implants are more likely successful when placed into
better quality bone in term of both quantity and density [180]. It is, therefore required to
have appropriate bone volume. In this study we are trying to find out whether anodization
of titanium helps in improving bone volume.
4.2

Materials and Methods

Titanium was first anodized by the anodic oxidation method, followed by the
surface characterization by the scanning electron microscope (SEM). Then the selected
titanium samples were used for cell culture work.
4.2.1

Anodization of Titanium
For Anodization of titanium, titanium was purchased from Goodfellow Cambridge

Ltd, UK. Titanium specimens of 0.5in x 0.5in (thickness 0.25mm) were cut from the
commercially 99.6+% pure titanium foils. Prior to further use, the specimens were
mechanically polished to a 0.05um diamond past finish, degreased by ultrasonic cleaning
in acetone, and air dried. During anodization, a circular area of 0.25 in was exposed to
the electrolytes. The counter-electrode was a platinum slate placed at a distance of 2cm
from the anode. All experiments were carried out at a constant cell voltage (range 1040V). The electrolyte was unstirred during anodization. The electrolyte was composed of
0.1 to IM H2SO4 and 0.05 to 0.9wt% HF, prepared from reagent grade chemicals and
deionized water. After the anodization, samples were thoroughly rinsed in DI water and
finely air dried.
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4.2.2

Surface Characterization of Titanium
The scanning electron microscope (SEM) was used to observe the surface

topography of the anodized titanium; electrically conductive carbon tapes were used for
mounting a titanium sample on SEM pin mount specimen holder. The double sided
adhesive tape allows faster sample mounting with no liquid or colloidal adhesives. It is
helpful for investigative samples in an uncoated state.
4.2.3

Osteoblast Cell Culture
After anodization and surface characterization, selected anodized titanium

samples were used for cell culture. Osteoblasts obtained from ATCC (7F2 CRL-12557)
were cultured on titanium samples for 14 and 21 days. The culture was incubated at 37°C,
5% C0 2 and 95% humidified air.
4.2.4

Cellular Characterization Methods

4.2.4.1 Cell Lysis Protocol
Osteoblasts cells were cultured in 12 well plates with three wells as negative
control, three wells as positive control, three wells as smooth titanium samples and three
wells as anodized titanium samples. Cells were detached from the plate and titanium
samples by trypsinization and transferred to 15ml tubes. They were centrifuged at
1200rpm for 5 minutes. The supernatant was discarded; and the pellet was resuspended in
300ul of the cell lysis solution. It was kept on ice for 15 minutes. It was then centrifuged
at 3200rpm for 20 minutes at 4°C. The supernatant was collected and stored at -70°C until
needed for further use.
4.2.4.2 DNA (PicoGreen) Assay
PicoGreen assay was used to measure the rate of cell proliferation. It was
determined by quantifying ds DNA content produced by dividing cells. DNA standers
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were prepared from DNA stock by diluting it in an appropriate amount of IX TE buffer
[158]. For standards, lOOul was mixed with 100(0,1 of picogreen working reagent. For
titanium samples, 100|il of cell lysate sample obtained from cell grown on titanium
samples was mixed with lOOul of picogreen reagent. It was incubated in dark at room
temperature for 2-5 minutes. Then from each tube lOOul was transferred in 96 black well
plates to avoid photodegradation. A fluorescence plate reader was used to detect
fluorescence emitted by the samples at an excitation wavelength of 485nm and emission
wavelength of 528nm.
4.2.4.3 Coomassie Plus Protein Assay
Fifty microliters (0.05ml) of each sample (cell lysate) was pipetted into the
appropriate test tube. Thousand five hundred microliters (1.5ml) of the Coomassie® Plus
Reagent was added to each well and mixed. The test tubes were incubated for 10 minutes
at room temperature. The absorbance was measured at 595nm with a spectrophotometer
[159].
4.2.4.4 Calcium (Alizarin Red) Staining
Alizarin red stain forms alizarin red S- calcium complex in the presence of
calcium.

The reaction complex formed can be recovered and measured at 410nm.

Alizarin Red solution (40mM) was prepared by adding 2g of Alizarin Red-S to 100ml of
distilled water. lOmM Sodium Phosphate solution was prepared by adding two different
solutions, solution A, consisting of 138g of Sodium Phosphate Dibasic in 100ml of
distilled water, and solution B, consisting of 142g of Sodium Phosphate Monobasic in
100ml of distilled water. Solution A (42.3ml) and Solution B (47.7ml) altogether made
100ml of lOmM sodium phosphate solution. To this solution, 10% cetyl pyridinium
chloride was added to prepare the destaining solution. The cells gown on titanium
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samples were then stained with alizarin red for 10 minutes. All the excess stain was
removed, and the scaffolds were destained with 10% cetyl pyridinium chloride in lOmM
sodium phosphate solution. This was measured on a spectrophotometer at 410nm.
4.2.4.5 Statistical Analysis
Analysis of variance (ANOVA) was used for quantitative analysis of osteoblast
cells proliferation, total protein synthesis and calcium deposition. In all these assays,
each reading was the mean of three trials to eliminate experimental errors. In this study,
ANOVA was used to assess the statistical difference between samples types (smooth
titanium and anodized titanium) and culture time. Here a was taken as 0.05. The null
hypothesis for this study stated that measured parameters such as osteoblast cells
proliferation, total protein synthesis and calcium deposition would not be affected by
factors such as surface roughness and different culture days. Additionally, an alternative
hypothesis stated that osteoblast cells proliferation, total protein synthesis and
mineralization would be affected by factor of surface roughness and different culture day.
Results of different assays will be considered significant when/><0.05.
4.3

Results

Anodization is a widely used surface modification technique for many metals by
varying voltage, molar concentration of sulfuric acid, and weight percent of hydrofluoric
acid. In this project, the anodization technique was used to produce nanoporous titanium.
Image Pro software was used to analyze the SEM images of anodized titanium samples to
determine inner pore diameter. In this study, the surface modification process was
performed using a hydrofluoric acid (HF) solution. Figure 4.2 shows titanium after the
anodization.
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Figure 4.2 Titanium After Anodization (0.5in x 0.5in).
4.3.1

Surface Characterization

4.3.1.1 Effect of Voltage
Results of this study indicated that cell voltage affects the pore size. Figures 4.34.7 show the SEM images of titanium oxide films obtained by the anodization in IM
H 2 S0 4 and 0.5wt% HF solution at room temperature at 15, 20, 25, 25 and 30V,
respectively. When 15V were applied, the average pore diameter was 215nm. For voltage
20, the average pore diameter was 78nm. For voltage 25, the average pore diameter was
297nm and for voltage 30, the average pore diameter was 268nm.
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Figure 4.3 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H 2 S0 4
and 0.5wt% HF at Room Temperature at 15V.

Figure 4.4 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H 2 S0 4
and 0.5wt% HF at Room Temperature at 20V.

53

5ft i •' \&f-«frl» ^ ^ ( & & t f £ *

Figure 4.5 SEM image of Titanium Oxide Films Obtained by Anodization in IM H2SO4
and 0.5wt% HF at Room Temperature at 25V.
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Figure 4.6 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H2SO4
and 0.5wt% HF at Room Temperature at 25V.
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Figure 4.7 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H2SO4
and 0.5wt% HF at Room Temperature at 30V.
4.3.1.2 Effect of Hydrofluoric Acid Concentration
According to the results of the current study, 0.5wt% HF concentrations worked
best for producing nanopores. As shown in Figure 4.9, titanium samples were anodized in
IM H 2 S0 4 and 0.5wt% HF at 20V; the average pore diameter was about 78nm. As the
HF concentration increased to 0.7wt% and 0.9wt% in IM H2SO4, the increased wt% of
HF yielded the almost completely etched titanium surface as shown in Figure 4.10. HF
concentrations of less than 0.5wt% resulted in the disordered and spongy-like, porous
titanium shown in Figure 4.8.
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Figure 4.8 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H 2 S0 4
and 0.15wt% HF at Room Temperature at 20V.
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Figure 4.9 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H 2 S0 4
and 0.5wt% HF at Room Temperature at 20V.
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Figure 4.10 SEM Image of Titanium Oxide Films Obtained by Anodization in IM H2SO4
and 0.9wt% HF at Room Temperature at 20V.
4.3.1.3 Effect of Molar Concentration of Sulfuric Acid
When Titanium was anodized in 0.1 M H2SO4 and 0.5wt% HF at 20V, there was
no pore formation. When the same molar concentration of H2SO4 and wt% of HF was
used at 25V, still there was no pore formation. As shown in Figure 4.11, when molar
concentration of sulfuric acid was increased to IM with 0.5wt% HF at 20V, nanopores
were present. Thus, these results indicate that IM concentration of H2SO4 was
responsible for the pore formation.
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jure 4.11 SEM image of Titanium Oxide Films Obtained by Anodization in
1MH 2 S0 4 and 0.5wt% HF at Room Temperature at 20V.
Table 4.1 shows different parameters affecting pore size. Based on results of
different experiments preformed, we have found that anodization in IM H2SO4 and
0.5wt% HF at room temperature at 20V is the excellent combination as it produced
uniform nanopores on the surface of titanium.
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Table 4.1 Different Parameters Affecting Pore Size.

1 M II sO
l) I M

H.so,

I M H.SO.
0 1 M H,SO,

I M H bO,
0 1 M H.bO,

No pores

215nm

No Pores

No Pores
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4.3.2

Cellular Characterization Analysis
7F2 osteoblast cells were cultured in tissue culture plastic. Osteoblasts were

obtained from ATCC (7F2 CRL-12557).

Figure 4.12 shows the growth of 7F2

osteoblast cells on days 1, 2, 3 and 4. On day 4, cells reached almost 85-90%
confluence. These cells were trypsinized and seeded on the PCL scaffolds, on the
halloysite-PCL scaffolds, on the smooth titanium, and on the anodized titanium. The
remaining cells were either plated again for culture or they were frozen.

Figure 4.12 Monolayer of Osteoblast on Day 1, Day 2, Day 3 and Day 4.
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4.3.2.1 DNA (PicoGreen) Assay
The PicoGreen assay was used as it provided accurate measurements on cellular
proliferation. This assay measures the total amount of ds DNA produced. The assay was
performed on 14 and 21 culture days to closely observe the cellular proliferation over 21
culture days. A high-range and low-range standard curve of fluorescence versus
DNA concentrations was generated by the lambda DNA standard to determine the
amount of ds DNA produced by the assay samples. DNA concentrations were
prepared by diluting the lambda DNA stock solution (2ug/ml) with the appropriate
amount of TE buffer and the PicoGreen working reagent as shown in Tables 4.2 and 4.3.
A standard curve was generated by plotting the fluorescence obtained for different
concentrations of the prepared DNA standards (ng/ml). The fluorescence value of the
reagent blank was subtracted from the measured values. Triplicate samples were
employed for each DNA concentration to ensure accuracy. Figure 4.13 shows a
high-range standard curve, and Figure 4.14 shows a low-range standard curve.
Table 4.2 Standards for High Range DNA Calibration Curve [158].
Volume(ul) of
Volume (ul) of 2|ag/ml Diluted Quant-iT
Volume (p.1) of TE
DNA Stock
PicoGreen
Reagent

Final DNA
Concentration in
Quant-iT PicoGreen
Assay

0

1,000

1,000

1 ug/ml

900

100

1,000

100 ng/ml

990

10

1,000

10 ng/ml

999

1

1,000

1 ng/ml

1,000

0

1,000

Blank
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Table 4.3 Standards for Low Range DNA Calibration Curve [158].

Volume (ul) of TE

Volume (ul) of
50 ng/ml DNA Stock

Volume(ui) of
Diluted Quant-iT
PicoGreen
Reagent

Final DNA
Concentration in
Quant-iT PicoGreen
Assay

0
900
990
999
1,000

1,000
100
10
1
0

1,000
1,000
1,000
1,000
1,000

25 ng/ml
2.5 ng/ml
250 pg/ml
25 pg/ml
Blank

High-Range Standard Curve

200

400

600
800
DNA (ng/ml)

1000

Figure 4.13 High-Range Standard Curve.
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Figure 4.14 Low-Range Standard Curve.
Cell lysate samples obtained from the osteoblast cells cultured on the nanoporous
titanium, on the smooth titanium, on the positive and on the negative control were
used for the assay. The assay was performed over a culture period of 21 days, on
14 and 21 days.

The lysate samples were placed in a 96 well plate, and the total

DNA content was evaluated with the addition of PicoGreen. The quantity of ds
DNA produced was measured from the fluorescing cell lysate samples at 528nm. The
standard curve was used to evaluate the quantity of ds DNA produced from the
fluorescence of the cell lysate samples. Each fluorescing value was a mean of the
triplicate samples employed.
It was observed that nanoporous titanium showed an increased rate of osteoblast
cell proliferation (Figures 4.15) on day 14, compared to the negative control, the positive
control and the smooth titanium. An enhanced proliferation was seen on culture day 21
compared to day 14 for the negative control (media and no cells), positive control (media
and cells) and smooth titanium (Figure 4.15 and Figure 4.16). On day 21, cell
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proliferation was decreased compared to day 14 for anodized titanium, but it was still
higher than the negative control, the positive control and the smooth titanium (Figure
4.15 and Figure 4.16). It was also observed that the cells' proliferative activity was
dependent on the substrates' surface roughness; thus, nanoporous titanium had a higher
rate of cell proliferation compared to the smooth titanium.

Titanium PicoGreen Assay
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Figure 4.15 Ti PicoGreen Assay Day 14 (/?>0.05 Not Statistically Significantly Different).
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Titanium PicoGreen Assay
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Figure 4.16 Ti PicoGreen Assay Day 21 (p>0.05 Not Statistically Significantly Different).
4.3.2.2 Coomassie Plus Protein Assay
Coomassie Plus protein assay was used to quantify the total protein production of
the negative control, the positive control, the smooth titanium and the nanoporous
titanium. The total protein content was assessed in cell lysate samples obtained from the
cells cultured on the negative control, the positive control, the smooth titanium and the
nanoporous titanium. Triplicates were used for each sample considered. The lysate of
0.05ml of each sample was mixed with 1.5ml of the Coomassie Plus reagent; the resulting
colorimetric reaction was measured for absorbance (595nm) and the total amount of
protein quantified.
Figures 4.17 and 4.18 depict the amount of total protein produced by osteoblasts
cultured on the negative control, positive control, smooth titanium and nanoporous
titanium at the culture period of 14 and 21 days respectively. Results indicated that the
total amount of protein production on nanoporous titanium was more than the negative
control, the positive control and the smooth titanium on day 14 and day 21. With time,
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protein synthesis was increased for both smooth titanium and anodized titanium; whereas,
it reduced slightly for positive control and negative control (Figures 4.17 and 4.18).

Figure 4.17 Ti Coomassie Plus Protein Assay Day 14 (p>0.05 Not Statistically
Significantly Different).
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Figure 4.18 Ti Coomassie Plus Protein Assay Day 2\(p<0.05 Statistically Significantly
Different)
4.3.2.3 Calcium (Alizarin Red) Assay
To estimate calcium-rich deposition by cells in a culture, Alizarin red assay is
used frequently. In this method dye from the stain cells can be extracted and evaluated.
Here, distaining is performed with 10% Cetyl pyridinium chloride in lOmM Sodium
Phosphate solution which can be measured by spectrophotometer at 410nm. Figures 4.19
and 4.20 shows the absorbance value of the alizarin red stain distained from the
monolayer on days 14 and 21, respectively. It was observed that anodized titanium
showed a higher absorbance value than the controls. The absorbance value increased
constantly with time for all the substrates except the positive control and the negative
control. Enhanced calcium deposition was seen on culture day 21 compared to 14 for the
smooth titanium and the anodized titanium. It was also observed that the cells' calcium
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deposition was dependent on the substrates' surface roughness; hence, more absorbance
was observed on nanoporous titanium.

Figure 4.19 Ti Alizarin Red Staining Day 14 (p>0.05 Not Statistically Significantly
Different).
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Figure 4.20 Ti Alizarin Red Staining Day 21(p>0.05 Not Statistically Significantly
Different).
4.3.2.4 Statistical Analysis of Results
Reading of cell proliferation, total protein synthesis and calcium deposition was
mean of three trials to remove experimental errors. The statistical significance of results
with respect to surface roughness and different culture period was analyzed using
ANOVA. The calculated/? value for total protein synthesis showed significant differences
for the employed samples (smooth titanium and anodized titanium) at different culture
period. Calculated p value of total protein synthesis for smooth titanium and anodized
titanium on day 21 found to be statistically significantly different.
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4.4

Discussion

Titanium is widely used in orthopedic and dental implants [162, 163]. However,
smooth titanium is not bioactive enough to form bonds with the bone, and hence, there is
a lack of osseointegration [93]. There are chances of implant failure or a shorter life of
the implant; so many attempts have been made to improve the surface properties of
titanium. Surface modification plays a very important role in the development of
biocompatible scaffolds. Previous studies have shown the importance of surface
topography in cell attachment and growth. Surface modification techniques (including
self-assembled monolayer, plasma spraying, laser surface treatment and microcontact
printing in conjunction with nanostructured materials such as protein, polymers and
nanoparticles) have shown promising results in terms of cell attachment and growth [44,
93]. Among the several surface modification techniques available, anodization is a wellestablished surface modification method. Anodization is performed in an electrochemical
cell which has a titanium anode and a platinum cathode. Constant voltage is applied
between the anode and the cathode. The degree of nanometer roughness after anodization
varies according to the process parameters such as voltage, electrolyte composition and
different kinds of acids. Compared to all the electrolytes, H2SO4 has shown the highest
oxide thickness. A fluoride solution was found to have the ability of producing a
biologically-inspired nano-tubular structure [44].

In this study we have used a

combination of H2SO4 and HF.
4.4.1

Effect of Hydrofluoric acid Concentration
Nanopores were produced when titanium samples were anodized in IM H2SO4

and 0.5wt% HF at 20V for 30 minutes. A HF concentration of higher than 0.5wt%
yielded completely etched titanium. These results disagree with a study done by Schmuki
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et al., that in IM H2SO4 containing HF concentration higher than 0.2wt% yielded a
completely etched titanium surface [182]. Previous findings suggest that disordered and
spongy, porous titanium oxide films were formed when anodization was performed in
H2SO4 containing 0.05wt% HF or less, but in this study a spongy nanoporous titanium
oxide file was produced below 0.5wt% HF [182]. According to Bestetti et al., by
increasing the HF concentration (0.15, 0.2, 0.3, 0.4wt%) in IM H2SO4 a more regular
porous structure is observed. The current study also disagrees with the results of the study
done by Bestetti et al [85].
4.4.2

Effect of Voltage
According to Bestetti et al., cell voltage significantly affects pore size [85]. When

increasing anodization voltages from 10 to 25 in increments of 5V in IM H2SO4 and
0.15wt% HF, an increase in pore diameter was observed while at a cell voltage higher
than 30V, the nanopores disappeared [85]. In the current study, as nano pores were not
formed at 0.15wt%, as discussed in the effect of hydrofluoric acid concentration. IM
H2SO4 and 0.5wt% HF were used for anodization of titanium at 15, 20, 25 and 30V.
Results of this study do not agree with results of bestetti et al [85]. An increase in pore
diameter was not observed with the increased in a cell voltage. Nanopores were formed at
all voltages (15, 20, 25 and 30V), but the pores formed at 20V were more uniform than
pores formed at other voltages.
4.4.3

Effect of Molar Concentration of Sulfuric acid
Titanium was anodized in 0.1 M H 2 S0 4 and 0.5wt% HF at 20V and 25V, but there

was no pore formation. However, pore formation was observed in IM H2SO4. Thus, in
this study, the best condition when nanopores were formed was IM H2SO4 and 0.5wt%
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HF at 20V for 30 minutes. These results are consistent with the results obtained by Gong
etal [183].
4.4.4

Cellular Characterization Analysis
Nanoporous surface topography on titanium is produced using anodization. In the

current study, nanoporous titanium showed higher cell proliferation, total protein
synthesis and mineralization (calcium deposition) compared to smooth titanium. Higher
cell proliferation results in more cell colonization on the implant surface, probably
leading to a larger mass of bone tissue around the implant. Faster cell differentiation may
result in faster maturation of bones around the implant and stronger bone-implant
bonding. Our results suggest that nanoporous surfaces may be biologically friendlier and
may promote multiple cell functions. The biological performance of the titanium
nanotube is still not well understood, and conflicting results have been reported. Our
study reveals the role played by nano-topographies on osteoblast function and provides
insights into future implant surface design.

CHAPTERS
HALLOYSITE-PCL COMPOSITES SCAFFOLD FOR
OSTEOBLAST TISSUE ENGINEERING
5.1

Introduction

Tissue engineering is an emerging field. It has many promising applications for
the development of novel artificial repair and replacement materials [184, 185]. This
material can be used in the treatment of tissue and organ regeneration [186, 187]. Tissue
engineering would be especially useful in developing bioengineered tissue for treatment
of orthopedic implants, dental implants and wound healing where current treatment
methods have proven refractory for many patients [188, 51]. The major component of
any tissue engineering approach includes cells and scaffolds [189, 190]. The current
study used PCL scaffolds, halloysite-PCL scaffolds and type I collagen coated halloysitePCL scaffolds.
Halloysite nanotubes can be loaded with different drugs, followed by their slow
release. The halloysite is an environmentally friendly object available in nature, which
can be used commercially. Halloysites are added to the PCL to make the halloysite-PCL
scaffold. PCL-scaffolds have been extensively studied and used in bone tissue
engineering applications. These PCL scaffolds possess preferred characteristics to be
used as a biodegradable scaffold. Polycaprolactone-based scaffolds generally tend to
degrade at a slow rate due to the high molecular weight and hydrophobic nature

72

73

[191]. When these scaffolds are used for dentoalveolar reconstruction, they should be
degraded over a long period of time. Now, researchers are trying to modify the
architecture and surface characteristics of scaffolds used for tissue engineering. A recent
study investigated whether the adding of halloysite in PCL scaffolds would modify the
surface characteristics and osteoblast growth on the scaffolds. If halloysite-PCL scaffolds
are proved to be biocompatible, then they can be used for drug-delivery in orthopedic
implants, dental implants and wound healing.
5.2

Materials and Methods

Electrospinning was used to make halloysite-PCL scaffolds. The arrangement of
halloysites and PCL fibers was characterized by the scanning electron microscope. To
further confirm the location of halloysites in halloysite-PCL scaffolds, halloysites were
labeled with FITC (Fluorescein isothiocyanate) and observed under the epifluorescence
microscope. Then, selected scaffolds were used for cell assays to assess biocompatibility
of halloysite-PCL scaffolds.
5.2.1

Preparation of Halloysite-PCL Composites
Scaffolds
An electrospinning technique was used for preparing PCL scaffolds, halloysite-

PCL scaffolds and drug-loaded halloysite-PCL scaffolds. The electrospinning set-up
consist of a syringe pump, syringe, plastic covering to enclose and stabilize the path of
the polymer jet, a collector plate, and high voltage electricity source. PCL (poly ecaprolactone) was used to make scaffolds. PCL beads were dissolved in chloroform overnight. The PCL chloroform mixture was taken in a 1ml syringe and released at lOul/min.
Flat head needles were used to dispense the polymer solution. The voltage supplied was
maintained at 17-20KV. The distance between the tip of the needle and the collector
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plate was maintained at 15 to 20cm for halloysite-PCL scaffolds and 25-30cm for PCL
scaffolds. The scaffolds made were then cut into 1cm squares. In electrospinning, a
syringe pump applies constant pressure to the syringe, and a high voltage is used between
the tip of the syringe needle and the grounded collector. A polymer jet starts to travel
towards the collection plate when the electric field strength is able to overcome the force
of surface tension of the solution droplet formed at the needle tip. During the travelling,
the solvent evaporates, and the scaffold is formed on the collector. In this project an
aluminum plate was used as a collector. Nine weight percent of PCL-chloroform mixture
was used for the PCL scaffold. For a halloysite-PCL scaffold, 2wt% halloysites were
added to 9wt% PCL-Chloroform mixture to make 2wt% halloysite-PCL scaffold.
Similarly, the 5wt% and 7% halloysite PCL scaffold were prepared.
5.2.2

Surface Characterization of PCL/Halloysite-PCL
Composites Scaffolds
A scanning electron microscope (SEM) was used to observe the surface

topography of the PCL scaffold and the halloysite-PCL scaffold; electrically conductive
carbon tapes were used for mounting samples on the SEM pin mount specimen holder.
5.2.3

Halloysite Labeling
Fluorescence

functionalization.

was

added

to

halloysites

HNTs

were

labeled

by

by

aminopropyltriethoxysilane

altering

their

surface

with

aminopropyltriethoxysilane (APTES). APTES (500ul) was dissolved in 6.25ml of
toluene to this 0.15g of clay powder was added, and then solution was ultrasonically
dissolved for 30 minutes. The solution was then refluxed at 120°C for 20 hours with
constant stirring. The resultant product was rinsed with toluene six times, followed by
drying overnight at 120°C. Then the mixture was rinsed 10 times with DI water followed
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by freeze-drying overnight. Three milligrams of these amino functionalized halloysites
were then added in 1.5ml of 0.1M carbonate buffer (pH 8.0). To this solution, 100(0.1 of
13mM solution of FITC in DMSO was added. This mixture was kept for 2 days with
constant stirring and protected from light. The solution was dialyzed and lyophilized
overnight [118]. An epiflurescent microscope was used for finding the location of the
labeled halloysite in the halloysite-PCL scaffolds.
5.2.4

Scaffold Sterilization
Scaffolds were cut into 1cm2 squares, and were then soaked in 95% alcohol for

48 hours. Scaffolds were washed with sterile distilled water two times and kept in
HBSS/DPBS -5X pen-strep for 24 hours. Before seeding cells on the scaffolds, they were
washed twice with the medium.
5.2.5

DNA (PicoGreen) Assay
The rate of cell proliferation on PCL scaffolds and halloysite-PCL scaffolds was

measured by PicoGreen assay. The rate of cell proliferation was determined by
quantifying ds DNA content produced by dividing cells growing on PCL scaffolds,
halloysite-PCL scaffolds and type 1 collagen coated halloysite-PCL scaffolds. lOOul of
the cell lysate sample obtained from the cells grown on PCL scaffolds, halloysite-PCL
scaffolds and type 1 collagen coated halloysite-PCL scaffolds were mixed with 1 OOul of
picogreen reagent, followed by incubation in the dark at room temperature for 2-5
minutes. Then from each tube, lOOul was transferred in 96 black well plates to avoid
photodegradation. A fluorescence plate reader was used to detect fluorescence emitted by
the samples at an excitation wavelength of 485nm and emission wavelength of 528nm.
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5.2.6

Coomassie Plus Protein Assay
Fifty microliters (0.05ml) of cell lysate from each sample was pipetted into the

appropriate test tube. Thousand five hundred microliters (1.5ml) of the Coomassie® Plus
Reagent was added to each test tube and mixed. The test tubes were incubated for 10
minutes at room temperature. The absorbance was measured at or near 595nm with a
spectrophotometer [159].
5.2.7

Calcium (Alizarin Red) Assay
The cells gown on PCL scaffolds and halloysite-PCL scaffolds were stained with

alizarin red for 10 minutes. All the excess stain was removed, and the scaffolds were
destained with 10% cetyl pyridinium chloride in lOmM sodium phosphate solution. This
was measured on a spectrophotometer at 410nm.
5.2.8

Statistical Analysis
Analysis of variance (ANOVA) was used for quantitative analysis of Osteoblast

cells proliferation, total protein synthesis and calcium deposition. In all these assays,
each reading was the mean of three trials to eliminate experimental errors. In this study,
ANOVA was used to assess the statistical difference between samples types (PCL
scaffold and type I collagen coated halloysite-PCL scaffold) and culture period. Here, a
was taken as 0.05. The null hypothesis for this study stated that measured parameters
such as osteoblast cells proliferation, total protein synthesis and calcium deposition, are
not affected by factor of sample type (PCL scaffold and type I collagen coated halloysitePCL scaffold) and different culture periods. And alternative hypothesis state that
Osteoblast cells proliferation, total protein synthesis and mineralization are affected by
sample type and different culture period. Results of different assays will be considered
significant when/?<0.05.
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5.3

Results

The electrospinning technique was used for fabricating PCL scaffolds and
halloysite-PCL scaffolds. Figure 5.1 shows a digital camera picture of the electrospun
PCL scaffold. The PCL fiber organization, the fiber diameter and the position of
halloysite in the PCL-halloysite were investigated by a scanning electron microscope
(SEM).

Figure 5.1 PCL Scaffold (4cm x 4cm).
5.3.1

PCL/ Halloysite-PCL Scaffold Characterization
Figure 5.2 shows a SEM image of the PCL scaffold. The average fiber diameter

of the PCL scaffold was 7 urn according to the SEM microscopic image scale.
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Figure 5.2 SEM
Figure 5.3 shows a SEM image of 2% halloysite-PCL scaffold. Two percent
halloysite-PCL scaffolds were fabricated by adding 2wt% of halloysites in 9wt% of PCL
chloroform mixture. SEM images show the bead formation, which was absent in the PCL
scaffold. Thus, these beads were formed because of the halloysite. This indicates that
halloysites get clustered together and form the beads.
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Figure 5.3 2% Halloysite-PCL Scaffold.
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Figure 5.4 shows a 5% halloysite-PCL scaffold. Hardly one bead was present in
the 5% halloysite-PCL scaffold. Bead formation should have been more than what was
observed in the 2% halloysite-PCL scaffold. Here, it looks like most of the halloysite was
incorporated into the PCL fiber or halloysites were pelleted at the bottom of the mixture.

Figure 5.4 5% Halloysite-PCL Scaffold.
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Figure 5.5 shows a 7% halloysite-PCL scaffold. Many beads were formed in the
7% halloysite- PCL scaffold. As the results for the 5% halloysite-PCL scaffold were
different from the 2% and the 7% halloysite-PCL scaffold, a confirmatory test was done
to find out the exact location of the halloysites in the halloysite-PCL scaffold. This
confirmatory test involved the fabrication of the FITC labeled halloysite-PCL scaffold.

Figure 5.5 7% Halloysite-PCL Scaffold.
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5.3.2

FITC Labeled Halloysite-PCL Scaffold
Characterization
Here, halloysites were labeled with florescent dye (FITC), and then added into the

PCL-chloroform mixture, followed by electrospinning. Therefore, wherever halloysites
were present in the scaffold, it would show bright green color under the epifluorescent
microscope. Figure 5.6 shows that florescence was present on the beads. This indicates
that the halloysites clustered together and formed the beads which were not getting
incorporated into the PCL fibers.

Figure 5.6 FITC Labeled Halloysite-PCL Scaffold.
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5.3.3

Analysis of Cellular Response

5.3.3.1 DNA (PicoGreen) Assay for Halloysite-PCL
Scaffold
The cell lysate obtained from the osteoblast culture on the type I collagen coated
halloysite-PCL scaffold, the halloysite-PCL scaffold, the PCL scaffold, the positive
control and the negative control were used for the assay. The assay was performed over a
culture period of 21 days, on the days 7, 14 and 21. The lysate were placed in a 96 well
plate to evaluate the total DNA content by addition of PicoGreen. The quantity of ds
DNA produced was measured from the fluorescing cell lysate sample at 528nm. The
standard curves were used to evaluate the quantity of ds DNA produced from the
fluorescence of the cell lysate sample. Each fluorescing value was a mean of the triplicate
samples employed.
It was observed that the type I collagen coated halloysite-PCL scaffold showed an
increased rate of osteoblast proliferation (Figure 5.7) compared to the negative control ,
the positive control, the PCL scaffold and halloysite-PCL scaffold on day 7.Whereas the
uncoated halloysite-PCL scaffold had lower cell proliferation compared to the type I
collagen coated halloysite-PCL scaffold, PCL scaffold and positive control. On day 7 the
PCL scaffold and halloysite-PCL scaffold both showed lower cell proliferation compared
to the positive control. The type I collagen coated halloysite-PCL scaffold showed
highest cell proliferation on day 7 compared to days 14 and 21 (Figures 5.7-5.9). For the
type I collagen coated halloysite-PCL scaffold, cell proliferation was lowest on Day 21.
For uncoated halloysite-PCL scaffold cell proliferation was maximum on day 14 (Figures
5.7- 5.9) compared to day 7 and day 21, but still it was less than cell proliferation
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observed on the type I collagen coated halloysite-PCL scaffold. Cell proliferation started
decreasing for both PCL scaffold and positive control after day 7.
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Figure 5.7 Halloysite-PCL Scaffold Picogreen Assay Day 7(p<0.05 Statistically
Significantly Different).
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Significantly Different).
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Figure 5.9 Halloysite-PCL Scaffold Picogreen Assay Day 21(p<0.05 Statistically
Significantly Different).
5.3.3.2 Coomassie Plus Protein Assay for Halloysite-PCL
Scaffold
The Coomassie Plus protein assay was used to quantify the total protein
production. The total protein content was assessed in the cell lysate obtained from the cell
culture on the negative control, the positive control, the PCL scaffold, the halloysite-PCL
scaffold and the type I collagen coated halloysite-PCL scaffold. Triplicates were used for
each sample considered. The lysates of 0.05ml of each sample were mixed with 1.5ml of
the Coomassie plus reagent; the resulting colorimetric reaction was measured at 595nm.
Results indicated that the total amount of protein production on the type I
collagen coated halloysite-PCL scaffold was more than the negative control, the positive
control, the PCL scaffold and the halloysite-PCL scaffold on day 14. Total amount of
protein production on the type I collagen coated halloysite-PCL scaffold was highest on
day 14 compared to day 7 and day 21 (Figures 5.10-5.12). For the halloysite-PCL
scaffold, total protein synthesis was highest on day 21 (Figure 5.12). It was more than the
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negative control, the positive control and the type I collagen coated halloysite-PCL
scaffold (Figure 5.12).
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Figure 5.10 Halloysite-PCL Scaffold Coomassie Plus Protein Assay Day 7 (p<0.05
Statistically Significantly Different).
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Figure 5.11 Halloysite-PCL Scaffold Coomassie Plus Protein Assay Day 14 (p<0.05
Statistically Significantly Different).
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Figure 5.12 Halloysite-PCL Scaffold Coomassie Plus Protein Assay Day 21 (p>0.05 Not
Statistically Significantly Different).
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5.3.3.3 Calcium (Alizarin Red) Assay for
Halloysite-PCL Scaffold
This is a sensitive method for quantification of the ARS in a stained monolayer by
distaining with 10% Cetyl Pyridinium Chloride in lOmM Sodium Phosphate solution
followed by colorimetric detection at 410nm. Figures 5.13 and 5.14 show the absorbance
value of alizarin red stain distained from the monolayer on days 7 and 14, respectively. It
was observed that the type I collagen coated halloysite-PCL scaffold showed higher
absorbance value than the halloysite-PCL scaffold, the PCL scaffold and the controls on
day 7 (Figure 5.13). The absorbance values were almost equal for halloysite-PCL scaffold
and the type I collagen coated halloysite-PCL scaffold on day 14 (Figure 5.14). For the
PCL scaffold, absorbance value decreased on day 14 compared to day 7 (Figures 5.13 and
5.14).
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Figure 5.13 Halloysite-PCL Scaffold Alizarin Red Staining Day 7 (p>0.05 Not
Statistically Significantly Different).
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Figure 5.14 Halloysite-PCL Scaffold Alizarin Red Staining Day 14(p<0.05 Statistically
Significantly Different).
5.3.3.4 Statistical Analysis of Results
The reading of cell proliferation, total protein synthesis and calcium deposition
was the mean of three trials to remove experimental errors. The statistical significance of
results with respect to sample type (PCL scaffold and type I collagen coated halloysitePCL scaffold) and different culture period was analyzed using ANOVA. The calculated p
values for cell proliferation assay and total protein synthesis showed statistically
significant differences for the different sample types (PCL scaffold and type I collagen
coated halloysite-PCL scaffold) on day 7 and 14. Cell proliferation was also statistically
significant differences for the different sample types on day 21. The calculated/? value
for calcium deposition showed significant differences between the sample type (the PCL
scaffold and the type I collagen coated halloysite-PCL scaffold) on day 14.
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5.4

Discussion

The electrospun PCL and halloysite-PCL fibers were fabricated and characterized
using SEM. Porous electrospun fibrous mats can mimic the extracellular matrix for cell
attachment, proliferation and differentiation and can be helpful for drug-delivery from the
fibers [192, 193, 194, 186]. According to study done by Qi et al., the addition of a small
quantity of halloysite does not significantly change the characteristics of the mats [195].
The current study supports the results of previous study showing that the addition of up to
2wt% of the halloysite in the PCL did not change its characteristics much. SEM images
of the halloysite-PCL scaffold show the beads formation, which was absent in PCL
scaffolds. These beads formed because of the presence of the halloysites. Therefore, here
it looks like that halloysites clustered together and formed the beads. A confirmatory test
was done to find out the exact location of the halloysite in the halloysite-PCL scaffold.
This confirmatory test was a fabrication of FITC labeled halloysite-PCL scaffold. Here,
halloysites were labeled with a florescent dye (FITC) which showed a bright green color
under the epifluorescence microscope. Since florescence was present only on the beads, it
indicates that halloysites clustered together and formed the beads and that they are not
getting incorporated into the PCL fibers. In the current study, the type I collagen coated
halloysite-PCL scaffold achieved higher cell proliferation, protein synthesis and
mineralization faster than halloysite-PCL scaffold and PCL scaffold. Higher cell
proliferation results in more cell colonization on the scaffold surface, probably leading to
a larger mass of bone tissue around the type I collagen coated halloysite-PCL scaffold.
Faster cell differentiation may result in faster maturation of bone around the type I
collagen coated halloysite-PCL scaffold.

CHAPTER 6
HALLOYSITE-PCL COMPOSITES SCAFFOLD FOR SUSTAINED
DRUG RELEASE
6.1

Introduction

Halloysites are naturally occurring nanotubes. The halloysites can be loaded with
different drugs and used for slower drug release [61]. This slower release lengthens the
effectiveness of the drug, as the drug comes out of the halloysites slowly. This helps in
extending the effectiveness of drugs without increasing dosage strength. Compared with
carbon nanotubes (CNTs), halloysite nanotubes are less expensive and have a larger
surface area [196, 197]. The advantages of using halloysites in drug-delivery are slower
release and reduced toxicity of drug. A drug-loaded halloysite can be added to the PCL
to make drug-loaded halloysite-PCL scaffolds that can be used as drug-loaded wound
care products. There are a number of potential benefits of these scaffolds, including the
elimination of the high initial delivery rate and a better safety profile. By using drugloaded halloysites, we can deliver drugs more uniformly, which will increase the
effectiveness of a clinical dose. Due to this efficiency, lower doses of drugs will be
required per patch. There are many different types of wound care products. The drugloaded halloysite delivery system is designed to offer superior clinical benefits over
current wound care systems, especially in the area of burn care. It will reduce the rate at
which a bandage needs to be changed. In the current study, we are making halloysite-PCL
scaffolds that can be used as a drug-loaded bandage in the future.
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6.2
6.2.1

Materials and Methods

Drug-Loading in Halloysites
The method for drug-loading in halloysite follows: Dissolve 20mg drug (Brilliant

Green,

Chlorhexidine,

Iodine,

Amoxycilline

and

Potassium

Clavulanate,

and

Doxycycline) in 1ml of water or alcohol. Sonicate it until the drug dissolves. Once the
solution becomes transparent add 50mg of halloysite powder. Sonicate again for 30
minutes. Then keep the solution in a vacuum machine and apply the vacuum for 20
minutes. After 20 minutes, stop the vacuum, remove the tube containing halloysites from
the vacuum machine. Keep it in room atmosphere for 20 minutes. Repeat vacuum process
three times. Followed by washing with water to remove any extra drug solution left
around halloysites. Figure 6.1 shows the drug-loading process in halloysites. When
vacuum is applied, air bubbles are removed from the halloysites. When the vacuum is
broken drug solution enters in to the halloysites [115]. As Povidone Iodine come in
solution form, so 50mg of halloysites were directly added into the 1ml of Povidone Iodine
solution. Twenty five milligrams of Curcuma Longa was dissolved in 1ml of water in this
solution 50mg of halloysite were dissolved. Followed by vacuum loading. Amoxycillin
and Potassium Calvulanate was obtained from Macleods pharmaceuticals, India.
Doxycycline was obtained from Shreya life science PVT. LTD, Roorkee, Uttarankhand,
India. Brilliant Green was obtained from Sigma.
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Figure 6.1 Drug-Loading in Halloysite [115].
6.2.2

Fabrication of Drug-Loaded PCL Scaffolds and
Halloysites-PCL Scaffolds
First, a PCL chloroform mixture was prepared by adding the appropriate weight

percent of PCL in the chloroform. The mixture was kept overnight. To this mixture, the
drug-loaded halloysites were added. Then, the solution was sonicated for 10 minutes
followed by electrospinning. For more detail see Section 5.2.1.
6.2.3

Fabrication of PCL/Halloysites-PCL Scaffolds
Containing Two Different Drugs
Electrospinning of the electrospinning mixture containing one type of drug was

performed until the scaffold is sufficiently thick; then electrospinning of the second
electrospinning mixture containing the second type of drug was performed over the first
layer of the scaffold. In the current study, Brilliant Green and Amoxycillin were used for
preparing the scaffold containing two layers of different drugs. Brilliant Green is green
and Amoxycillin is white. Then, the fiber organization was observed under the
microscope.
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6.2.4

Drug Release from Drug-Loaded Halloysites
Drug-loaded halloysites were added into 1ml of water, incubated on magnetic

stirrer for 10 minutes, and centrifuged at 7000rpm for 2 minutes. The supernatant was
taken into the fresh tube and marked as #1 tube. To the pellet 1 ml of water was added,
and it was incubated again on the magnetic stirrer for 10 minutes. Then, centrifuged at
7000rpm for 2 minutes. The supernatant was taken in the fresh tube and marked as #2
tube. To the pellet 1ml of water was added. This process was repeated utill desired. The
magnetic stirrer was taken out, and then the concentration of the drug released was
measured with the UV Spectrometer and calculated. The difference between absorption
maximum and 800nm was taken, than it was multiplied by dilution factor. Concentration
at each time was found by adding up concentration. This was divided by total
concentration and multiplied by hundred.
6.2.5

Drug Release from PCL scaffolds and
Halloysites-PCL scaffolds
Take 0.1 gm of the drug-loaded PCL scaffold/drug-loaded halloysite-PCL scaffold,

and add 5ml of water. Incubate on magnetic stirrer for 1 month. Take out the supernatant
at different time intervals. Measure the concentration of the drug released with the UV
Spectrometer.
6.2.6

Bacterial Studies
A bacterial experiment was performed to find out the effect of the drug released

from halloysites-PCL scaffold on the bacteria. One liter of LB broth was prepared by
mixing lOgm of NaCl, lOgm of tryptone, 5gm of yeast extract, 15gm of agar, and
enough distilled water to make a final volume of 1 liter. This LB broth was sterilized by
autoclaving at 121 C for 15 minutes. After autoclaving, LB broth was poured into
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different plates, which were allowed to solidify overnight. The next day, a loop full
culture of Escherichia coli (E. coli) bacteria was spread on the LB broth plates. Bacteria
were allowed to grow overnight. Next day, drops of drug released from halloysite-PCL
scaffold were kept on the bacterial culture in the LB broth plate. The effect of the drug
was observed the next day.
6.3

Results

Loading of the halloysites with drugs was based on the vacuum cycling of a
halloysite suspension in a saturated drug solution, as was described earlier. The air
located in the pores of the halloysites was replaced by the drug solution during this
process. This cycle was repeated three times in order to get the highest loading. Brilliant
Green, Chlorhexidine, Iodine, Curcuma Longa, Povidine Iodine, Amoxycillin and
Potassium Calvulanate and Doxycycline drugs were used for loading in the halloysites.
6.3.1

Drug Release from Halloysites
Figures 6.2 - 6.8 show drug release profiles form the halloysites for Brilliant

Green, Chlorhexidine, Iodine, Curcuma Longa, Povidone Iodine, Amoxycillin and
Potassium Calvulanate, and Doxycyclin respectively.

A drug release study was

performed in water at room temperature. The suspension of the halloysite nanotubes was
constantly stirred with the magnetic stirrer during the entire release process in order to
establish an equilibrium condition. Samples for analysis were taken from the suspension
by centrifugation. Concentration of the drug was determined by UV spectrophotometer.
Here, 96.52% of Brilliant Green was released from halloysites in the first 5 hours (Figure
6.2); 84.95% of Chlorhexidine was released from halloysites in the first 4 hours (Figure
6.3); 92.68% of Iodine was released from halloysites in the first 5 hours (Figure 6.4);
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93.4% of Curcuma Longa was released from halloysites in the first 8 hours (Figure 6.5);
76% of Povidone Iodine was released from halloysites in the first 6.5 hours (Figure 6.6);
94.83% of Amoxycillin and Potassium Calvulanate was released from halloysites in the
first 5 hours (Figure 6.7); and 98.73% of Doxycycline was released from halloysites in
the first 4 hours (Figure 6.8).

Figure 6.2 Brilliant Green Release Profile from Halloysites.
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Figure 6.3 Chlorhexidine Release Profile from Halloysites.
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Figure 6.4 Iodine Release Profile from Halloysites.
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Figure 6.5 Curcuma Longa Release Profile from Halloysites.
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Figure 6.6 Povidone Iodine Release Profile from Halloysites.
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Figure 6.7 Amoxycillin and Potassium Calvulanate Release from Halloysites.

Drug Release from Doxycyclin Loaded Halloysites
120
100

8

80

v ^ " — ~ o~~

J- V "

%

01
01

tc 60
60
3

_

40
20

2
3
Time (Hours)

Figure 6.8 Doxycycllin Release from Hallloysites.
6.3.2

Drug Release from PCL/Halloysite-PCL Scaffold
Figures 6.9 and 6.10 show drug release profiles form the Brilliant Green loaded

PCL scaffold and the Brilliant Green loaded halloysites-PCL scaffold, respectively. A
drug release study was performed in 5ml of water at room temperature. The suspension
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containing the drug-loaded scaffold was constantly stirred with the magnetic stirrer during
the entire release process in order to establish an equilibrium condition. Samples for
analysis were taken at specific time intervals. The concentration of the drug was
determined by UV spectrophotometer. It was observed that 98.58% of Brilliant Green was
released from the Brilliant Green loaded PCL scaffold in 25 days (Figure 6.9), and 100%
of Brilliant Green was released from Brilliant Green loaded halloysite-PCL scaffold in 5
days (Figure 6.10). Figure 6.11 shows the absorption maximum for Brilliant Green. The
absorption maximum for Brilliant Green was 623nm. It was seen that 91.67% of
Amoxycillin and Potassium Calvulanate was released in 9.6 days from Amoxycillin and
Potassium Calvulanate loaded halloysite-PCL scaffold (Figure 6.12) and 97.46% of
Amoxycillin and Potassium Calvulanate was released from Amoxycillin and Potassium
Calvulanate loaded PCL scaffold in 5.6 days (Figure 6.13). Further, 95.16% of
Doxycycline was released from Doxycycline loaded PCL Scaffold (Figure 6.14). Figure
6.15 shows absorption maximum for Amoxycillin and Potassium Calvulanate, which was
274nm.
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Figure 6.9 Drug Release from Brilliant Green Loaded PCL Scaffold.

Drug Release from Brilliant Green Loaded Halloysite-PCL
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Figure 6.11 Absorption Maximum for Brilliant Green at 623nm.
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Figure 6.12 Drug Release from Amoxycillin and Potassium Calvulanate Loaded
Halloysite-PCL Scaffold.
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Figure 6.14 Drug Release from Doxycycline Loaded PCL Scaffold.
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Figure 6.15 Absorption Maximun for Amoxycillin and Potassium Calvulanate at 274nm.

6.3.3

Drug-Loaded PCL Scaffolds and Halloysites-PCL
Scaffolds
Scaffolds were examined under the microscope. Figure 6.16 shows fiber

arrangement in a band aid obtained from Johnson and Johnson company. These fibers do
not contain any drug. Figures 6.17-6.19 show fiber arrangements in an Amoxycillin
loaded PCL scaffold, a Brilliant Green loaded PCL scaffold, and a scaffold containing
two drug layers (a Brilliant Green loaded PCL layer and an Amoxycillin loaded PCL
layer) respectively. The Amoxycillin loaded PCL scaffold showed white color as
Amoxycillin is white (Figure 6.17). The Brilliant Green loaded PCL scaffold showed a
green color as Brilliant Green is green (figure 6.18); whereas, the scaffold containing two
drug layers (a Brilliant Green loaded PCL layer and an Amoxycillin loaded PCL layer)
showed both white and bluish green colors (Figure 6.19).
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Figure 6.16 Band-Aid (Johnson and Johnson).
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Figure 6.17 Amoxycillin Loaded PCL Scaffold.

Figure 6.18 Brilliant Green Loaded PCL Scaffold.
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Figure 6.19 Brilliant Green Loaded PCL+ Amoxycillin Loaded PCL Scaffold.
6.3.4

Bacterial Studies
A bacterial study was done to find out the effectiveness of the drug released from

the halloysites-PCL scaffold on E.coli. A bacterial culture of E.coli was spread on an
agar plate and lines were drawn on the outside of the plate to create "sectors". These
bacterias were allowed to grow overnight. The next day, drops of drug released from
halloysites-PCL scaffold was kept in one sector, and the plates were allowed to grow
overnight again at 37°C. The next day, bacteria were killed in a region where a drop of
the drug released from halloysites-PCL scaffold was kept (Figure 6.20). Here,
Amoxycillin and Potassium Calvulanate released from halloysites-PCL scaffold was
used. In Figure 6.20 arrow indicates the areas were bacteria were killed.
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Figure 6.20 Effect of Amoxycillin and Potassium Calvulanate Released from
Halloysite-PCL Scaffold on Bacteria.

108
6.4

Discussion

Halloysite nanotubes have a high specific surface area [120]. For halloysite
nanotubes, the capillary force is very high. This results in a quicker adsorption of
materials. Absorption of small molecules mainly takes place by their intercalation into
interlayer space [122, 123, 124]; whereas, big molecules and drugs are bound to the
outer and inner faces of halloysites [111, 125]. The adsorptive properties of halloysites
are significantly affected by their surface charges. These surface charges are pHdependent [110, 40]. Brilliant Green, Chlorhexidine, Iodine, Curcuma Longa, Povidine
Iodine, Amoxycillin and Potassium Calvulanate, and Doxyxycline drugs were
successfully loaded into halloysites. A drug release study was performed in water at room
temperature. The suspension of the drug-loaded halloysite, the drug-loaded PCL scaffold
and the drug-loaded halloysite-PCL scaffold was constantly stirred with a magnetic stirrer
during the entire release process in order to establish an equilibrium condition. Samples
for analysis were taken from the suspension by centrifugation. The concentration of the
drug was determined by UV spectrophotometer. Each drug had a different release profile.
This indicated that the halloysite can be used for drug-delivery. Ninety six percent of
Brilliant Green was released from the halloysite in the first 5 hours. Ninety eight percent
of Brilliant Green was released from the Brilliant Green loaded PCL scaffold in 25 days,
whereas, 100% of Brilliant Green was released from the Brilliant Green loaded halloysitePCL scaffold in 5 days. These results indicate halloysites, PCL scaffold and halloysitePCL composite scaffolds can be used for sustained drug release. Results of Amoxycillin
and Potassium Calvulanate drug release from halloysites, PCL Scaffold and halloysitePCL scaffold also indicate that drug-loaded halloysites, PCL Scaffold and halloysite-PCL
scaffold can be used for sustained drug release. According to this study, we can fabricate
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scaffolds containing two or more different drug-loaded layers and we can create a scaffold
where drug 1 is loaded into the halloysite, drug 2 is loaded into the PCL fibers and drug 3
is coated on the surface of the scaffold.

CHAPTER 7
CONCLUSION
In this dissertation, two different materials were nanoengineered for application in
regenerative medicine. The first material used was titanium and the second was
halloysite-PCL scaffold. The present study investigated anodized titanium, as a surface
modified nanoporous substrate. Uniform nanopores of 78nm diameter were produced by
optimizing the wt% of HF, applying the voltage and using two different molar
concentration of H2SO4. Nanoporous titanium showed higher cell proliferation, total
protein synthesis and mineralization compared to smooth titanium.
The fabrication of the halloysite-PCL scaffold was optimized by using different
wt% of the halloysite in the PCL-chloroform mixture. The location of the halloysite in the
halloysite-PCL scaffold was finalized by use of SEM and FTIC labeling of the halloysite.
2wt% halloysites in the PCL-chloroform mixture gave the best architecture. Up to 7wt%
halloysites produced a fair quality of the halloysite-PCL scaffold. The type I collagen
coated halloysite-PCL scaffold achieved higher cell proliferation, protein synthesis and
mineralization faster than the halloysite-PCL scaffold and the PCL scaffold.
According to the current study, we can construct a scaffold containing two or
more drug-loaded layers. We can also create a scaffold where drug 1 is loaded into the
halloysite, drug 2 is loaded into the PCL fibers and drug 3 is coated on the surface.
Brilliant Green release from the drug-loaded Halloysites, the drug-loaded PCL scaffold
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and the drug-loaded Halloysites-PCL scaffold were observed. Results show that the drugloaded Halloysites-PCL scaffolds and the drug-loaded PCL scaffold were more effective
in delivering drugs over a longer period of time compared to drug-loaded halloysites.
Therefore, the PCL/halloysite-PCL scaffold can be used as a drug-loaded band aid for
sustained drug release in the future.

CHAPTER 8
FUTURE WORK
Several studies can be done in the future to further build upon the obtained
results. Future studies need to be done to advance this development such as:
•

Use of local anesthetic drug, anti-inflammatory drugs, growth factors and other
drugs for encapsulation and sustained release from halloysite.

•

Check the effect of the growth factor loaded halloysite-PCL scaffold on
osteoblasts.

•

Application of layer-by-layer assembly, using various polymers on the drugloaded halloysite-PCL scaffold as an additional step for controlled for drug
diffusion.

•

Elaboration of drug-loading study of halloysite for application in cosmetics.

•

Investigate the growth of osteoblasts on nanoporous titanium loaded with growth
factors.

•

Try a combination of nanoporous titanium and layer-by-layer technique.

•

Nanoporous titanium with surface functionalization with bioactive coating such as
collagen should be tested.

•

Check the hybrid micro/nano-textured titanium surface for osteoblast growth.

•

In the SEM image (Figures 8.1 and 8.2) white clay (multani mitti) looks similar to
halloysites, so further study should be done to find out its properties.
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Figure 8.1 SEM Image of White Clay (Multani Mitti).

Figure 8 2 SEM Image of White Clay (Multani Mitti).

APPENDIX A
PREPARATION OF COMPLETE a-MEM
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Materials and Equipment Needed
aMEM (alpha minimum essential medium), fetal bovine serum and antibiotic
(AB) were used.
Method
Complete aMEM (alpha minimum essential medium) is prepared by mixing 90%
aMEM with 2mM L-glutamine and ImM sodium pyruvate without ribonucleosides and
deoxyribonucleosides, 10% fetal bovine serum and 1% antibiotics.

APPENDIX B
THAWING CRYOPRESERVED VIALS
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Materials and Equipment Needed
Cryovials containing osteoblasts, 75% alcohol, centrifuge tubes, complete aMEM
and tissue culture flasks were used.
Method
A liquid nitrogen tank contains different containers labeled with varying colours.
Cryovials of different cell lines are placed in different containers. The log book is
checked before taking out cryovials from the liquid nitrogen. When removing cryovials
from the liquid nitrogen, protective goggles and gloves need to be worn. After removing
from the cryovials cap need to be loosened to release liquid nitrogen trapped in the
threads of vial. Re-tight the cap and using a float lower half of the vials was placed in
water at room temperature to thaw. Sterilize the exposed area of the vial with 75%
alcohol before using it. Transfer the suspension to the centrifuge tube from the vial so
that nothing will be left in the cryovial. Add complete aMEM to the desired
concentration. Centrifuge it. Discard the supernatant, resuspend the pellet in complete
aMEM. Plate the desired number of cells on a tissue culture flask. Ensure the uniform
distribution of cells in the the flask to avoid clumps of cells. Incubate the cells at 37°C,
5% CO2 and 95% air in a humidified cell culture incubator.

APPENDIX C
CELL CULTURE
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Materials and Equipment Needed
Seventy percent ethanol, cryovial floating membrane or thawing cells, culture
dishes, pipetting aids, sterile pipettes, disposable centrifuge tubes, pipette tips, flask and
funnel, hemacytometer, light microscope and 37°C incubator were used. Hanks buffer
saline solution (HBSS), trypsin and complete media aMEM were also used.
Method
Laminar hood was cleaned with 70% alcohol. The laminar hood was turn on for
30 minutes so that the laminar hood will be sterilized. Then the cell culture works was
started. aMEM was taken out from the refrigerator and equilibrate to 37°C. Sterilization
of the bottle surface was done with 70% alcohol in sterile hood. Cryopreserved vial of
cells was taken out from the liquid nitrogen storage tank. Osteoblasts were obtained from
ATCC (7F2 CRL-12557).
Proper protection for the eyes and hands was used. The cryovial of the cells was
kept in a 37°C water bath for thawing. Once it was thaw; it was wiped with 70% alcohol.
Cells in the cryovial were transferred to the centrifuge tube, containing 5ml of the
complete aMEM. It was centrifuged at 1.2rpm for 7 to 10 minutes. The supernatant was
discarded because it contains cell freazing media. The pellet was resuspend in 5ml of
complete aMEM. It was transfer into culture dishes. Add some more medium if needed.
The culture was incubated at 37°C, 5% CO2 and 95% humidified air.

APPENDIX D
SUBCULTURING OF THE CELLS
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Cell Check
Check for the presence of microbial contamination every day. Using a
microscope, check for the confluency of the culture every day. Once the cells become
confluent, subcultivate them to keep the cells actively growing.
Harvestine of Cells
Pre-warn HBSS, IX Trypsin and Complete aMEM medium to room temperature.
Take out and discard the medium using sterile pipette from the culture dish. Wash the
cell monolayer two times with 5ml of HBSS. HBSS washing is followed by, addition 35ml of IX Trypsin and incubate for 5 minutes at room temperature. Check for the
detachment of the cells under the microscope. When the cells start detaching, take out all
the media with a sterile transfer pipette and transfer it to a centrifuge tube. Centrifuge at
1.2rpm for 10 minutes. Discard the supernatant. Resuspend the pellet in 5ml of Complete
aMEM. Transfer it into culture dishes. Add some more medium if needed. Incubate the
culture at 37°C, 5% C0 2 and 95% humidified air.

APPENDIX E
CRYOPRESERVATION OF THE CELLS
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Materials and Equipment Needed
Extra osteoblast cells, sterile cryovials, liquid nitrogen and cell freezing medium
were used.
Method
Extra osteoblast cells were stored in cryovials in liquid nitrogen for long-term
use. The temperature of the liquid nitrogen was maintained at -80°C. Extra Osteoblasts
were collected in a centrifuge tube. They were counted for cell numbers. They were
centrifuge at 1.2rpm for 7 to 10 minutes. The supernatant of complete aMEM was
discarded. The cells were resuspended in cell freezing medium (complete aMEM + 10 %
DMSO) at a concentration of about 10 - 10 cells/ml. The cryovials were filled with 11.5ml of cells suspended in a freezing medium. Before the cryovials were stored at
-80°C, they were initially stored for about 6 hours at 4°C and then for 24 hours at -20°C.

APPENDIX F
CELL COUNTING

125
Materials and Equipment Needed
Hemocytometer, osteoblast cells and microscope were used.
Method
A hemocytometer is used for counting the osteoblast cells per unit volume of a
suspension. Cover slips used for the counting chambers are thicker than the usual
microscopic cover slips. The cover slip is kept over the counting surface then cell
suspension is dropped into one of the V-shaped wells. Due to this, the area under the
cover slip fills by capillary action. Once the counting chamber is filled, then the counting
grid is focused at a low power. The counting chamber has nine large squares. Each
square has an area of 1mm and the depth of 0.1mm. The osteoblast cell suspension was
dilute enough so that the cells do not overlap each other and uniformly distribute on the
counting chamber. The central large square was selected to perform the count.
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